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ABSTRACT 
Dietary Management of Phenylketonuria 
A wider understanding of the impact of each of the dietary components on blood 
phenylalanine concentrations in PKU may lead to improvements in management. 
Knowledge of the effects of such rigorous diet therapy on feeding behaviour is also 
important. In a series of studies, the effect of a number of dietary factors on plasma 
phenylalanine control and of diet on feeding behaviour was systematically investigated. 
The key findings were: 1) there is wide variability in plasma phenylalanine concentrations 
which were not reflected in a single early morning phenylalanine measurement; 2) plasma 
phenylalanine concentrations were more influenced by the timing and dosage of protein 
substitute than by total energy or excess natural protein intake from ‘freely’ allowed foods; 
3) repeated 4 hourly administration of protein substitute throughout 24-hours markedly 
reduced phenylalanine variability and led to lower phenylalanine concentrations; 4) ‘free’ 
use of fruits and vegetables containing phenylalanine between 51-100 mg/100g did not 
adversely affect plasma phenylalanine control; and 5) feeding problems were common, with 
almost 50% of young children with PKU exhibiting at least 3 feeding problems. These 
findings in PKU are important in the understanding of feeding behaviour; the interpretation 
of plasma phenylalanine concentrations; they increase and rationalise the range of ‘free’ 
foods; and will reduce 24-hour plasma phenylalanine variability, and thus, possibly increase 
dietary phenylalanine tolerance. 
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Fig 1.1 Treated and untreated children with PKU.  
The boy aged eleven is severely retarded while his 2 year old sister is normal. 
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1.1 Background information 
Phenylketonuria (PKU) is an autosomal, recessive, genetic disorder (Costello et al, 1994). It 
is usually caused by a deficiency of the hepatic enzyme, phenylalanine hydroxylase 
(phenylalanine 4-mono-oxygenase, EC 1.14.16.1). This is a mixed function oxidase which 
catalyses the hydroxylation of phenylalanine to tyrosine, the rate limiting step in 
phenylalanine catabolism (Woo et al, 1986). Deficiency of this enzyme leads to an 
accumulation of phenylalanine, resulting in hyperphenylalaninaemia and abnormalities in the 
metabolism of many compounds derived from aromatic amino acids. The enzyme deficiency 
varies from complete absence of detectable activity, up to a residual activity up to 25% or 
more (Smith et al, 1991). Overall, the frequency among Caucasians is approximately 1 in 
10,000 (Bickel et al, 1981), corresponding to a carrier frequency of about 1 in 50. 
Untreated PKU leads to mental retardation (Fig 1.1), hyperactive behaviour with autistic 
features, and seizures (Waisbren and Zaff, 1994). Treatment is a strict low phenylalanine 
diet, and if started within the first 3 weeks of life, irreversible mental retardation is prevented 
(Tyfield et al, 1990). Even when diet is started early, intellectual and neurological 
development may still be compromised both in early childhood and in adult life. 
1.2 History 
Classical PKU was first recognised by Asbjörn Fölling in 1934 (Fölling, 1934 a,b). He 
found and identified phenylpyruvic acid in the urine of two mentally retarded siblings. He 
later identified a further 8 children, from 430 mentally retarded patients, who had the same 
acid in their urine. Of the 10 detected children, there were 4 pair of siblings, suggesting this 
was a hereditary condition. Fölling suspected that phenylalanine might be the most probable 
source of the phenylpyruvic acid. He found that phenylalanine and a protein load each 
3 
separately increased phenylpyruvic acid excretion. He proposed that this was an autosomally 
transmitted recessive disorder of phenylalanine metabolism which he called imbecillitas 
phenylpyrouvica. In 1935, Penrose confirmed that this disorder was inherited as an 
autosomal recessive trait, and introduced the term phenylketonuria (Penrose, 1935). 
It was a further 15 years before the biochemical basis of phenylketonuria was more 
specifically defined. In 1947, Jervis observed that the administration of phenylalanine to 
normal humans led to prompt elevation in serum tyrosine but this response was absent in 
patients with PKU (Jervis, 1947). In 1952, the enzyme system capable of converting 
phenylalanine to tyrosine was identified (Undenfriend and Cooper, 1952). A year later it was 
demonstrated that post-mortem liver samples from normal individuals were able to convert 
phenylalanine to tyrosine in vitro, while those from PKU patients were not (Jervis, 1953). 
A low phenylalanine diet for the treatment of PKU was suggested by Woolf and Vulliamy 
(1951). This was first given to a 2 year old child with PKU at Birmingham Children's 
Hospital by Bickel, Gerrard and Hickmans (1 953). The child had severe developmental 
problems; was unable to stand, walk, or talk; and spent her time groaning, crying and head 
banging. During treatment with a low phenylalanine diet there was a gradual improvement 
in the child's mental state. She learnt to walk, crawl, stand, climb on chairs, ceased head 
banging and her hair grew darker. A blind challenge with 5g L-phenylalanine led to the child 
becoming distressed and a recurrence of the head banging within 6 hours. Within 20 hours, 
she could no longer stand and could hardly crawl. 
This case report was quickly followed by other studies demonstrating that a 
low- phenylalanine diet, if given early in infancy, prevented the mental and neurological 
deterioration otherwise almost inevitable in PKU (Woolf, Armstrong and Tyler, 1955; 
Blainey and Gulliford, 1956; Horner and Steamer, 1956; Low, Bosma and Armstrong, 1957; 
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Woolf et al, 1958). However, there was an apparent inverse relationship between the time of 
starting therapy and clinical outcome. The later the diet was started; the less the benefit. 
These observations stimulated interest in neonata1 screening programmes for 
phenylketonuria (Eisensmith and Woo, 1991). 
The first screening programme, based on the urinary ferric chloride test, was implemented in 
California, USA, in 1957 (Centerwall, 1957), and later in the UK (Gibbs and Woolf, 1959; 
Boyd, 1961). Unfortunately the ferric chloride test had limited utility in widespread 
screening procedures, as the harmful elevation of blood phenylalanine precedes urinary 
excretion of phenylpyruvate (Armstrong and Binkley, 1956). False negative results were 
therefore common place. In 1963, Guthrie and Susie (Guthrie and Susie, 1963) discovered 
that blood phenylalanine could be easily measured in a semi-quantitative manner by a 
bacterial inhibition assay. This method required only a small amount of blood, and was 
specific, inexpensive and well-suited to analysing a large number of samples. It was adopted 
as a routine procedure to screen all newborn babies for PKU in most Western countries. 
The original diet developed by Woolf and colleagues (Woolf and Vulliamy, 1951) has 
formed the basis of the current dietary approach. It consisted of a protein hydrolysate treated 
with activated charcoal to remove phenylalanine and tyrosine. The daily intake of casein 
hydrolysate was maintained relatively high because of possible inefficient protein utilisation. 
Extra tyrosine, methionine and cysteine were added together with vitamins and mineral salts 
(Table 1.1). It was supplemented with additional carbohydrate because it had already been 
shown that this enhanced utilisation of amino acids (Munro and Thomson, 1953). The 
protein substitute mixture was given in the form of a soup, and in older patients was only 
administered once daily. Cow's milk was given as the chief source of phenylalanine and a 
phenylalanine exchange system was introduced for older children who were allowed to 
replace cows milk with defined and strictly controlled amounts of cereal and potato. 
5 
A small range of foods were allowed freely. They included vegetables (except potatoes and 
pulses ), oranges, apples, cornflour, sago, Kosher margarine, sugar, honey, jam, and low 
protein bread and biscuits made from gluten-free wheat starch. From 1957, the casein 
hydrolysate, supplementary amino acids, and mineral salts were provided by the National 
Health Service, but the gluten-free wheat starch had to be purchased by parents. 
A UK conference on PKU in 1963 made a number of recommendations to the Medical 
Research Council about its management (MRC, 1963). Concern was expressed about over- 
treatment of PKU. There had been a number of reports of lethargy, listlessness, anorexia, 
poor weight gain, vomiting and even death which appeared to be due to phenylalanine 
deficiency in PKU infants and young children. For the first time guidance was given on 
desirable phenylalanine concentrations and frequency of blood phenylalanine monitoring. 
It was considered safer to maintain blood phenylalanine concentrations at between 1.5 and 
4 mg/100 ml phenylalanine (90 and 240 mol/l) which was slightly above the normal 
reference range (0.93 ± 0.27 mg/100 ml or 56 ± 16 mol/l). One year later, the Medical 
Research Council and Department of Health and Social Security set up a National Register 
for PKU to document the clinical and intellectual progress of patients treated with a low 
phenylalanine diet. This was followed by the initiation of the United States Collaborative 
Study in 1967, which investigated the effectiveness of diet within the first 6 years of life and 
the need to continue diet beyond 6 years of age. 
Over the last 30 years, the duration of diet has been the subject of much discussion and 
policy change. In the 1960's and 1970's, many PKU centres stopped diet as early 4 or 
8 years, when it was argued brain development would be substantially complete. Initial 
reports on stopping diet were conflicting. Some studies showed no intellectual deterioration 
following discontinuation of diet therapy (Kang et al, 1970; Holtunan, Welcher,and Mellitts, 
6 
Table 1.1 
Original ‘milk’ given to babies.with PKU (Woolf et al, 1958) 
* Acid hydrolysed casein passed through charcoal to remove phenylalanine and tyrosine. 
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1975; Chang et al, 1983; Saudubray et al, 1987); others showed falls in IQ (Smith et al, 
1978; Hudson et al, 1970; Cabalska et al, 1973). The age of continuing either a strict or 
relaxed diet has gradually extended, and in the early 1990's diet for life was recommended in 
the UK (MRC, 1993a). 
1.3 Classification of PKU 
Phenylalanine hydroxylase deficient hyperphenylalaninaemia can be divided into two 
main types depending on residual enzyme activity. 
1. Classical ur severe PKU. This is usually characterised by plasma phenylalanine 
concentrations over 1,000 mol/l (an arbitrary threshold) at presentation (Scriver et al, 
1995), but sometimes even in excess of 3,000 mol/l. There is an almost a complete loss 
of enzyme activity (Ledley, Levy, and Woo, 1986) and in the liver phenylalanine 
hydroxylase activity is 0.3% or less of normal (Hilton et al, 1986). Historically, the 
condition is called 'classical' and in the UK almost 80% of all patients fall into this 
category of hyperphenylalaninaemia (Costello et al, 1994). 
2. Persistent hyperphenylalaninaemia. This is a milder form of the disorder in that there is 
only a partial reduction in the activity of the phenylalanine hydroxylase enzyme from 2 to 
5% of normal (Ledley et al, 1986). On a normal diet, the plasma phenylalanine will 
range from 120 to 1,000 mol/l (Scriver et al, 1995). In the UK, 2 1 % of all patients who 
have elevated phenylalanine have mild hyperphenylalaninaemia (Costello et al, 1994). 
Strict definition holds that there should be no urinary excretion of phenylpyruvic acid. 
However, in practice, there are 'borderline' patients who will occasionally excrete 
phenylpyruvic acid in easily detectable amounts, depending on dietary intake and other 
factors (Pollitt, 1994). Although this is sometimes referred to as benign 
hyperphenylalaninaemia, it has been shown to adversely affect intellectual ability 
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(Costello et al, 1994). It is recommended that all children who have phenylalanine 
concentrations of 400 mol/l or above should follow a low phenylalanine diet (MRC, 
1993b) at least in early childhood. A restriction of natural protein is not recommended 
for children with phenylalanine concentrations below this concentration. 
There are also rarer forms of hyperphenylalaninaemia due to a deficiency of reductase or 
other enzymes involved in the biosynthesis of tetrahydrobiopterin (Kaufman et al, 1975, 
1978; Leeming, Blair and Rey, 1976). These tetrahydrobiopterin deficiency disorders are 
sometimes referred to collectively as malignant hyperphenylalaninaemias, but the clinical 
picture is variable and some patients are only moderately affected, presenting late with 
mental retardation. A low phenylalanine diet is not effective. In Caucasian populations only 
1-2% of cases of hyperphenylalaninaemias have tetrahydrobiopterin deficiency defects 
(Pollitt, 1994). 
1.4 Does outcome in early-treated PKU relate to quality of 
control of blood phenylalanine? 
Monitoring of PKU treated continuously and carefully following neonata1 diagnosis has 
demonstrated that a low phenylalanine diet prevents mental retardation. Most early treated 
children who have started diet by 4 weeks of age fall within the broad normal range of 
general ability and attend mainstream schools (MRC, 1993a; Weglage et al, 1993). 
However, studies have indicated that the IQ of children with PKU is still significantly below 
population norms and that of unaffected siblings (Smith et al, 1990; Smith et al, 1991 ; 
Holtzman et al, 1986). Deficits have also been documented in information processing, 
abstract reasoning, high level problem solving, behaviour and linguistic ability. There is 
strong evidence to indicate that outcome is closely related to the quality of blood 
Phenylalanine control, particularly during pre-school and early school years (MRC, 1993a). 
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1.4.1 Effect on IQ 
Three large national studies have investigated the quality of dietary control and effect on IQ 
in children. 
1. United States Collaborative PKU study 
This prospective longitudinal and randomised study was conducted in two parts at 19 
treatment centres throughout the United States between 1967 to 1983. Part A compared 
strict with moderate restriction of phenylalanine during the first six years of life, while part B 
investigated diet continuation versus discontinuation after six years of age (Azen et al, 
1996). An early report of 111 children at the age of four years, indicated that the children in 
the two treatment groups had a comparable mean IQ of 93. However, many of the children 
could not be maintained in the specified treatment category and there was considerable 
overlap of serum phenylalanine concentrations between the two groups (Dobson et al, 1977). 
In a follow-up report from the same study, the average IQ at 6 years of age for 132 subjects 
was 98, but was found to be significantly related to mother's IQ, the age at initiation of 
treatment and the phenylalanine concentrations during the first six years of life 
(Williamson et al, 198 1). 
In part B, a strong correlation between the age of loss of dietary control (ie. blood 
phenylalanine concentrations greater than 900 mol/l) and cognitive test scores at 8 years 
and 10 years of age was demonstrated (Holtunan et al, 1986). It was also reported that the 
children with the lowest IQ's were those who had ceased dietary control before 6 years of age 
(Koch et al, 1987). Children who stayed on diet had higher reading and spelling scores at 10 
years of age compared with those who stopped diet, but arithmetic, language and perceptual 
test scores declined uniformly in both groups from ages 6 to 10 years (Fishler et al, 1989). 
Overall, children with PKU, experienced more school problems (Koch et al, 1987), had 
lower IQ's, and lower Wide Range Achievement Test scores (WRAT) than their unaffected 
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siblings and parents (Holtzman et al, 1986). However, for children who were still on diet at 
the age of 8 years, the deficit was reduced for IQ when compared with their parents and did 
not exist when compared with their siblings. The authors strongly recommended the early 
initiation of dietary treatment and continuation throughout childhood (Azen et al, 1996). 
2. German Collaborative PKU study. 
One hundred and sixty five children were enrolled in the West German PKU collaborative 
study born between 1978-1984. They aimed to maintain plasma phenylalanine 
concentrations between 120 mol/l and 240-360 mol/l, but the means of median 
concentrations were greater than 360 mol/l from from the age of 2 years onwards, and 
subsequently settled at concentrations of 420 mol/l (Michel, Schmidt, and Batzler, 1990). 
Cluster analysis data was reported from this longitudinal study focusing on intelligence at 
4,5 and 9 years of age. This was related to the quality of dietary control (ie. phenylalanine 
concentrations below 300 mol/l, 360-600 mol/l, and above 600 mol/l) and in comparison 
with 200 healthy controls (Burgard et al, 1996). On average, all three levels of dietary 
control scored significantly lower than healthy age peers, but children with phenylalanine 
concentrations below 360 mol/l had IQ's within the normal range. Full scale IQ's were not 
significantly different between good and moderate phenylalanine control but in the poor 
dietary control group, the mean IQ was 10 points below the scores of the healthy control 
group. 
3. UK MRC PKU register 
Smith et al, (1 990) reported results from two cohorts of patients with phenylketonuria bom 
between 1964 and 1971 (cohort 1), and 1972 to 1980 (cohort 2). Fewer than 10% achieved 
good treatment results and the mean IQ of patients born in the mid 1970's was 8 points below 
the norm. Nineteen percent of patients in cohort 1 and 8 % of patients in cohort 2 had IQ's 
that were more than 2 standard deviations below the norm. The IQ fell by 0.28 of a standard 
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deviation (4 points) for each month delay in starting treatment, for each 300 mol/l rise in 
phenylalanine concentration, and for each 5 months during the first 2 years which 
phenylalanine concentration was below 120 mol/l. In a further report from the same two 
cohorts of patients, Smith et al, (1 99 1) reported that the mean phenylalanine concentration 
rose from around 400 during the first 4 years to above 900 by 12 years. Those 
patients with good control throughout the first 8 years had better standard deviation scores 
(SDS) at 8 years, those with good control in the first 4 years but poor control between 
4 and 8, did less well, and those with poor control throughout the first 8 years had the 
greatest IQ change. In those with good control after 4 years, IQ SDS stayed the same or 
showed a rise. In those patients born in the second cohort, an inverse association between 
intelligence and phenylalanine control persisted to at least 1 O years, although the association 
was less marked than at earlier ages. 
Adolescents and young adults 
There is less clear evidence that high blood phenylalanine concentrations adversely affect IQ 
after the early teenage years. A further follow-up study from the UK MRC PKU register of 
the intellectual status of 192 patients at the age of 18 years, revealed that mean IQ's were 
significantly below population norms. Twenty seven percent had IQ's over two standard 
deviations below the estimated population mean. They showed a small decrease in IQ from 
14 to 18 years of age. This was significantly related to average phenylalanine control 
between birth and 14 years and between 14 and 18 years. Only 5% of the patients had 
phenylalanine concentrations below 700 In this study there was no control group, 
and the authors suggest the apparent fall in IQ-SDS between 14 and 18 years was due to 
methodological problems. They concluded that the general ability in young adults is reduced 
in comparison with their peers, but is more closely related to phenylalanine control in early 
childhood than in later years (Beasley, Costello and Smith, 1994). 
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In Gemany, Schmidt et al, (1 996) investigating a group of 51 young adults treated for PKU 
before 3 months of age, have reported that their mean IQ was 97. On average, their median 
phenylalanine concentration was below 300 up to the age of 10 years, below 600 
mol/l up to 15 years and later approximately 900 Of the IQ's only 4% were more 
than 2 standard deviations below the norm, and IQ's did not deteriorate after the age of 10 
years. The results were better than the UK MRC PKU follow-up study, and may reflect 
better German blood phenylalanine control in the first 10 years of life. 
These studies would therefore indicate there is a close relationship between intellectual 
development in children with PKU and their dietary control. Intelligence decreases linearly 
with higher blood phenylalanine concentrations in children before mid-childhood. However, 
studies of early treated subjects with good dietary control suggest that the risk of intellectual 
deterioration declines dramatically in later childhood and adolescence. 
1.4.2 Outcome measures other than IQ 
Neuropsychological studies 
Results of studies investigating problem solving, reaction times and sustained attention in 
PKU are summarised in Table 1.2 and 1.3. Deficits were found in information processing, 
abstract reasoning, both in conceptual and visuospacial areas and high level problem solving 
Waisbren et al, 1994; Brunner, Berch, and Berry, 1987; Pietz et al, 1992; Schmidt et al, 
1992). Children with PKU who had remained on restricted diet performed better than those 
who had terminated diet, although most studies documented that performance was most 
closely related to concurrent phenylalanine concentrations or concentrations within the 
previous two years (Waisbren et al, 1994). 
In the few neuropsychological studies in early treated adult patients (Ris et al, 1994; Pietz et 
al, 1993), sustained attention has been shown to improve with lower blood phenylalanine 
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concentrations, but to deteriorate after dietary relaxation (Schmidt et al, 1994). Not all 
studies have reported abnormal neuropsychological test scores with high blood phenylalanine 
concentrations. Griffiths and co-workers (Griffiths et al, 1997) in a randomised crossover 
study, gave a high phenylalanine supplement for 3 months to sixteen 10 - 16 year old 
patients with PKU on diet. Mean phenylalanine concentrations were increased from 834 
to 1355 Intellectual ability, memory, and conduct were not affected by 
medium term hyperphenylalaninaemia. 
Neurological symptoms 
Neurological signs e.g. excessively brisk tendon jerks, ankle clonus and intention tremor 
have been noted in children with early treated PKU with high blood phenylalanine 
concentrations and in young adults returned to a normal diet (Smith et al, 1985; 
Thompson et al, 1990). 
Severe neurological deterioration has been noted in at least 10 adults, all who had poor 
dietary control or had stopped diet in their early teens. Firstly, Villasana and co-workers 
(Villasana et al, 1989) reported neurological deterioration in 2 adult patients who stopped 
dietary treatment at 6 and 12 years respectively, although the latter did not start diet until he 
was 3 years of age. Neurological complications included rapidly progressive spasticity and 
increase in seizure frequency in the first patient and gradual deterioration in school 
performance, behaviour and concentration in the second. Thompson et al, (1 990) described 
7 adult patients in the UK, who developed quadriparesis, paraparesis, tremor and ataxia. 
Only 4 of these patients started diet early in infancy and all had stopped or relaxed diet 
before teenage years. A further case study, described a 19 year old male with PKU who 
developed a spastic paraparesis 8 months after stopping a low phenylalanine diet. He had 
always had poor dietary control, but also had a borderline low serum vitamin B12 
concentration on presentation, although this was not attributed to his problem. His brother, 
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who also had PKU, had ceased dietary therapy, but his only neurological abnormality was a 
slight increase in his deep tendon reflexes of the lower limb (McCombe et al, 1992). He had 
poor dietary control reported through teenage years. 
Neuroradiological studies (magnetic resonance imaging: (MRI)) have commonly revealed 
white matter abnormalities of the brain in older patients (Leuzzi et al, 1993; Bick et al, 1993; 
Thompson et al, 1993; Toft et al, 1994; Pietz et al, 1996). White matter abnormalities have 
been observed in both inpatients with late onset neurological symptoms and in symptom-free 
patients remaining on diet. Most of the MRI scans have revealed symmetrical patchy and/or 
band-like areas of enhanced signal intensity (Ullrich et al, 1994). These changes 
predominantly affect the posterior/periventicular white matter; areas which are thought to 
show the latest myelination in humans. More extensive lesions affecting the frontal and 
subcortical white matter have been reported (Ullrich et al, 1994). It has been shown that the 
extent of the MRI changes is closely and independently associated with the degree of 
hyperphenylalaninaemia at the time of investigation, and with the number of years since the 
subjects stopped taking a low phenylalanine protein substitute (Thompson et al, 1993). 
Some workers have returned patients to a stricter low phenylalanine diet to investigate if the 
abnormalities in cerebral white matter are reversible (Cleary et al, 1995; Walter et al, 1997; 
Battistini et al, 1991). Cleary et al, (1 995) documented significant improvement in MRI 
findings in the adult patients when blood phenylalanine concentrations were reduced below 
900 The greatest changes were seen in those patients who maintained blood levels 
below 400 Complete reversal of moderate/severe brain MRI abnormalities were 
noted in a single patient with classical PKU who reduced blood phenylalanine concentrations 
to less than 450 (Walter et al, 1997). 
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Although abnormal EEG finding have been noted in 12 - 15 year old PKU children, and 
advance with increasing age independantly of IQ development, there is no relation to either 
the age at onset or the quality of dietary treatment (Pietz et al, 1988). 
Psychological outcomes 
Behaviour problems have been documented in early treated 8 year old PKU children 
particularly in those with poor dietary control. Data from the UK/MRC study indicated that 
patients maintaining blood phenylalanine concentrations below 600 from cohorts 1 
and 2 (groups previously defined) were respectively 1.5 and 1.7 times more likely to have 
deviant behaviour whilst those patients maintaining blood phenylalanine concentrations over 
600 were respectively 2.5 and 1.9 times more likely to have behaviour problems 
(Smith et al, 1988). Patients with PKU were more likely to have mannerisms, show signs of 
anxiety, hyperactivity, be less responsive and more solitary than controls. Stevenson and co- 
workers (Stevenson et al, 1979) found that treated boys with PKU more frequently exhibited 
deviant behaviour than expected in the general population. 
However, not all studies have demonstrated behaviour problems. Using a personality 
questionnaire, Weglage et al, (1 994) demonstrated that the only difference between 1 O year 
old children with PKU and a comparable control group was that they were more sensitive, 
empathetic and less masculine in their attitudes. Only six children from this study had poor 
dietary control (ie phenylalanine concentrations greater than 600 after the age of 
3 years). 
Although there is evidence that early treated PKU young adults function in a productive 
manner in society (Koch et al, 1985; Schmidt et al, 1996), there are reports of psycho-social 
difficulties and psychiatric disorders in adults with PKU (Fisch et al, 1995; Ris et al, 1997; 
Waisbren et al, 1994). Waisbren et al, (1 994) reported greater psychopathy in a group of 12 
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young women with PKU who had either started diet late or who had terminated diet for at 
least five years, when compared with an early treated group who had remained continuously 
on diet. In an early study, Waisbren and Levy (1991) described agoraphobia in five young 
adults with PKU. All five received a low phenylalanine diet only in early childhood, and 
three had started diet therapy after 3 months of age. However, when two of the women 
returned to a low phenylalanine diet, they had a dramatic reduction in symptoms. 
Other studies have demonstrated no relationship between blood phenylalanine 
concentrations, duration of diet and psychological or psychiatric symptoms in early treated 
adults. Ris et al, (1 997) studied psychosocial adjustment of 25 early treated patients with 
PKU aged 18 years and older. Most psychosocial measures were indistinguishable from 
sibling controls. However, on a self-report inventory of psychiatric symptoms, 20% of the 
patients demonstrated significant morbidity. Patients with PKU were more likely to be 
troubled by persistent impulses and thoughts that were unwanted as well as feelings of 
alienation and discomfort in interpersonal situations. There was no significant correlation 
with early dietary control. 
In a controlled trial, in a group of 35 early treated patients with PKU, aged 17 to 33 years, 
Pietz et al, (1 997) found psychiatric disorders in 25.7% of patients with PKU and in 16% of 
the control group. In the group with PKU, introversive symptoms were increased, whilst 
extroversive symptoms decreased. Problems included depressed moods, phobias, 
generalised anxiety, hypochondriac worries and anxiety at work. They were more common 
in women. No correlation was found between severity or pattern of psychiatric disorders and 
biochemical control. However, a restrictive controlling style of parenting was found to be a 
risk factor in the development of psychiatric symptoms. 
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Therefore, outcome in early treated subjects with PKU is not as good as first thought. 
Impairments are more closely linked with the quality of blood phenylalanine control than 
previously recognised. Studies have revealed intellectual, neurological and 
neuropsychological deficits as well as abnormalities of cerebral white matter in patients with 
early treated PKU. Whilst it is accepted that adverse effect of IQ can be reduced by 
implementation of diet as early as possible in the neonata1 period, questions remain about the 
optimum blood concentration of phenylalanine in the treatment of PKU. 
1.5 What should blood phenylalanine concentrations be in 
PKU? 
Since the early 60’s it has been PKU policy to maintain blood phenylalanine concentrations 
above normal (MRC, 1963) with upper limits of 600 for young children. However, 
there is now compelling evidence that a persistently raised concentration of blood 
phenylalanine over 400 in infancy and early childhood correlates quantitatively with a 
reduction in IQ (Smith et al, 1990; Smith et al, 1991). Costello et al, (1 994) described the 
outcome at the age of 4 years of 24 untreated patients with ‘atypical mild PKU’ and blood 
phenylalanine concentrations consistently below 900 IQ was 9 points below 
population norms and IQ fell progressively by 6 points for each 100 rise in 
phenylalanine concentration. More recently, Diamond et al, (1 997) found in a 4 year 
longitudinal study, that children with PKU whose blood phenylalanine concentrations were 
three to five times normal (360-600 performed less well on tasks that required the 
working memory and inhibitory control abilities dependent on the prefrontal cortex. 
However, although there is clear evidence that blood phenylalanine concentrations should 
not exceed 360-400 in younger children (Table 1.4), aiming at ‘normal’ 
concentrations runs the risk of phenylalanine deficiency. There is evidence that this may be 
harmful to intellectual, neurological and nutritional status (Smith et al, 1990; 
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Table 1.4 
Blood phenylalanine: normal and recommended concentrations in 
PKU 
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Sutherland, Umbarger, and Berry, 1966; Sutherland, Umbarger, and Berry, 1970; Hanley, 
1970). As a result of these findings, general UK recommended guidelines for desirable 
blood phenylalanine concentrations in young children are still above normal phenylalanine 
concentrations and are between 120 - 360 (MRC, 1993b). An upper limit of 
480 is suggested for school age children, and 700 in older children only 
because it is recognised that it is difficult to maintain lower blood phenylalanine 
concentrations in older patients. However, the recommended blood phenylalanine range of 
120 - 360 for younger children is still lower and narrower than has been maintained 
for over 30 years in PKU, and the newly recommended phenylalanine concentrations raise 
two issues: 
i) 
ii) 
Knowledge of the extent of diurnal variation of blood phenylalanine in PKU 
Appropriate blood sample timing in PKU 
i) Knowledge of the extent of circadian variation of blood phenylalanine in 
PKU 
Feigin, Klainer and Beisel (1 967) first reported in normal infants a circadian periodicity of 
‘total serum amino acids’ which was assumed to be more or less independent of meals. 
Information on blood phenylalanine fluctuations over 24 hours in PKU would be similarly 
important. As well as providing valuable information on the stability of blood phenylalanine 
concentrations in PKU, it would be helpful in the interpretation of single blood 
phenylalanine estimations. 
Unfortunately, information on the circadian rhythm of plasma phenylalanine concentations in 
patients with PKU is both limited and conflicting. Güttler et al, (1 969) identified 
phenylalanine concentrations to be higher in the morning than evening in two children with 
PKU aged 3 years, but phenylalanine was measured at only two time points on each of three 
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consecutive days. Mean blood phenylalanine concentrations varied by almost 
100 between morning and evening, and evening serum phenylalanine was lower 
in the children with PKU than normal controls. In a single case study of a pregnant PKU 
patient, plasma phenylalanine concentrations were shown to vary by 200 in 
24 hours (Farquhar, Steven and Westwood, 1985). 
In contrast, van Spronsen concluded that the daily fluctuation in plasma phenylalanine 
concentrations in PKU was small (van Spronsen et al, 1993). In this study, measurements 
were made at 30 minute intervals for 5 hours from before breakfast to 2 hours after the 
midday meal. In eight out of nine patients variation was less than 43 although one 
older patient did vary by 285 Phenylalanine concentrations increased rather than 
decreased over the period studied. 
Results from non-PKU human studies (Feigin et al, 1967; Wurtman et al, 1968) and in an 
experimental animal (Feigin et al, 1969; Eriksson et al, 1989; Cai et al, 1994) are more 
consistent. In humans, the concentrations of most amino acids generally peak during the 
afternoon and reach their lowest point by 04.00h in the morning, whereas in rat this is 
reversed. Scriver and co-workers found the maximum concentration difference for 
phenylalanine to be less than 50%, when phenylalanine concentrations were measured four 
times daily under fasting and non-fasting conditions in a group of 10 healthy adults (Scriver 
et al, 1985) A further study investigating plasma amino acid values in normal children 
showed little variation (Gregory et al, 1986). However, this study examined only inter-, 
subject variation and single blood specimens were taken at different times during the 
morning and early afternoon; dietary intake was uncontrolled. 
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ii) Blood sample timing in PKU 
Even though the study results on phenylalanine variability are contradictory, it has been 
recommended that single blood phenylalanine specimens be taken at a standard time, ideally 
early morning when concentrations are likely to be at a peak (MRC, 1993b). It may be that 
single-point, early morning, phenylalanine concentrations are misleading in PKU, 
particularly if blood phenylalanine concentrations vary by as much as 100-200 as 
suggested by Güttler et al, (1 969) and Farquhar et al,(1985). Theoretically if an early 
morning phenylalanine concentration is just above the MRC lower limit of 120 and 
decreases by over 100 during the day, phenylalanine concentrations could be very 
low for a considerable time in the second half of the day (MRC, 1993b). Similarly, if blood 
phenylalanine concentrations increase during the day, as suggested by van Spronsen’s data 
(van Spronsen et al, 1993), it is possible that an early morning phenylalanine concentration 
just within the MRC upper limit in the early morning may exceed target levels during the 
remainder of the day (MRC, 1993b). 
Further assessment of 24 hour variability of blood phenylalanine concentrations is therefore 
necessary both to test the validity of a single morning blood specimen and to determine if it 
is possible to maintain blood phenylalanine concentrations within the new guideline for 
recommended blood phenylalanine concentrations over a full 24 hour period. 
1.6 Is the structure of the existing diet capable of 
consistently maintaining blood phenylalanine 
concentrations with i n target rang es? 
The structure of the UK PKU diet is based on procedures developed in the 1950’s and has 
subsequently developed by custom and practice. It has rarely been critically examined and 
no published study has attempted to evaluate existing diet therapy or modify practices 
systematically, even though many problems and anomalies have been recognised 
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(MacDonald, 1995; MRC, 1993a). The structure of the UK diet is quite different from 
systems used in other countries (Fig 1.2). It consists of four parts: 
1. Daily allowance of dietary phenylalanine from measured quantities of moderate protein 
containing foods to provide phenylalanine requirements. 
2.  Provision of a phenylalanine-free protein substitute in order to meet nitrogen 
requirements. 
3. Maintenance of a normal energy intake. 
4. Provision of all vitamins and minerals to meet dietary requirements. 
This system for allocating phenylalanine has been widely criticised, both within the UK 
(MRC, 1993a) and by dietitians in other countries (personal communication). It is thought 
more likely than systems in use in other countries to lead to higher or unstable phenylalanine 
concentrations. In the UK, children with classical PKU maintaining blood phenylalanine 
within the target range of 120-360 usually tolerate between 200-400 mg of 
phenylalanine daily, which would be found in 4-8g of natural protein. The system used does 
not permit high protein foods such as meat, fish, eggs, cheese, nuts, ordinary bread, biscuits 
and pasta, but allows a measured intake of moderate protein containing foods e.g. cereals, 
potato and some vegetables. These are given in the form of an exchange system, whereby 
one food can be exchanged or substituted for another of equivalent phenylalanine content. 
The idea of an exchange system was introduced as early as 1958 and the principles have 
changed little since. In the UK, a 50 mg phenylalanine exchange system is used. When 
phenylalanine data analysis of specific foods is not available, 1 g protein is assumed to 
contain 50 mg phenylalanine (Barnes, 1994). USA and Australia use a 15 mg phenylalanine 
exchange system (Lyman and Lyman, 1960; Thompson, 1997), and calculate the 
phenylalanine content of all foods given in the diet. There are four specific problems which 
have been identified with the UK PKU diet: 
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Fig 1.2 
Pictorial description of the low phenylalanine diet 
used in the treatment of PKU. 
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1. Phenylalanine per unit weight variability 
For many years, due to a lack of data on the phenylalanine content of different proteins, 
phenylalanine exchanges have been based on protein content rather than actual amino acid 
analysis. The assumption that 1 g of protein contains 50 mg phenylalanine, does not apply to 
fruit and vegetables. Indeed most vegetables only contain 35 mg phenylalanine per gram of 
protein. However, there are a number of inconsistencies. For example, one gram of protein 
from asparagus contains 13 mg phenylalanine; whilst one gram of protein from spinach 
contains 140 mg of phenylalanine (Table 1 S). Therefore, using exchanges adapted from 
protein data will provide only approximate intakes of phenylalanine. These may not be 
accurate enough to achieve and maintain the new blood phenylalanine lower target ranges. 
The last published comprehensive phenylalanine analysis was in 1979 (Paul et al, 1980). It 
contained information about a limited range of foods. The most recent edition of ‘The 
Composition of Foods’ indicated that the protein value of many foods had slightly changed. 
In 1996, the Leatherhead Food Research Association and Laboratory of the Government 
Chemist analysed the phenylalanine content of 100 common fruit and vegetables 
(Weetch et al, 1997). Reassuringly, there was good correlation with the 1979 phenylalanine 
data. However, there remains wide gaps in knowledge about the phenylalanine content of 
many of the natural and manufactured foods commonly eaten by children and adults with 
PKU. 
2. Fruit or vegetable variability 
The category allocation of many fruits and vegetable in the PKU diet has caused particular 
controversy and debate. Some which contain less than 2.0g protein/100g are included as part 
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of the exchange system: others which contain more than 1.0g protein/100g are allowed as 
free foods. In particular, cauliflower and mushrooms which are relatively high in 
protein are allowed freely. A child who eats a portion of mushrooms and cauliflower within 
the same day, could be having the equivalent of two extra phenylalanine exchanges. There is 
no rational explanation for these practices. Indeed, in 1993, the MRC Working Group on 
PKU recommended that in order to maintain plasma phenylalanine concentrations within 
lower and narrower limits, these higher protein vegetables should be incorporated into the 
50 mg phenylalanine exchange system in order to moderate their use in PKU. However, the 
contribution of protein or phenylalanine from these higher protein free vegetables to the PKU 
diet and the effect on control has not been assessed and warrants further investigation. 
3. Free food definitions vary 
The free food system accompanying the 50 mg phenylalanine exchange system has a number 
of limitations. There is no agreed definition of a ‘free’ food. The system generally includes 
all fruits and vegetables containing less than 50 mg phenylalanine/100g, other commodities 
which contain less than 0.3g protein/100g and low protein special products containing less 
than 20 mg/100g phenyalalanine. However, some higher phenylalanine/protein fruits and 
vegetables are permitted, and foods such as sauces (containing up to 2.0g/100g protein), 
butter (0.5g protein/100g), and some low protein breads and pasta (containing over 25 
mg/100g phenylalanine) are allowed freely. The effect on plasma phenylalanine 
concentrations of such additional phenylalanine from free sources is unknown. Similarly, 
there are no data quantifying the contribution to the total diet of protein and phenylalanine 
from free foods, or it’s effect on day to day plasma phenylalanine concentration variation. 
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Table 1.5 
Phenylalanine content of fruit and vegetables 
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4. Exchange system may be too sensitive 
Allocation of dietary phenylalanine by a single tier 50 mg exchange system may not be 
sufficiently sensitive to maintain phenylalanine concentrations within the narrow limits 
recommended by the MRC (MRC, 1993b). The use of alternative exchange systems need 
consideration. Possible options include: a) a two tier exchange system using a combination 
of 50 mg and 25 mg exchanges; and b) calculating the phenylalanine content of all foods 
given to a child with PKU. Both options would ensure that most of the existing ‘free’ 
vegetables which contain significant quantities of protein would be included as part of a 
measured phenylalanine exchange system. Although there is merit in these systems, they 
would make the diet even more complicated and restrictive. They may potentially increase 
parental anxiety, cause feeding problems in younger children, and lead to cheating in older 
children as a result of the fewer free foods from which to choose. A two-tier phenylalanine 
exchange system was used in the UK previously, but abandoned in the early 1980’s. No 
adverse effect on control was reported, although the effect of this dietary change was not 
specifically monitored. There has been no attempt to compare blood phenylalanine control 
and the psychosocial outcome of different dietary regimens for allocating phenylalanine. 
1.7 Other dietary factors which may affect control in PKU 
1.7.1 Protein substitutes 
It has been suggested that the composition, quantity and diurnal distribution of the amino 
acid intake could be important in PKU and influence blood phenylalanine control (MRC, 
1993a). Protein substitute was found to suppress blood phenylalanine concentrations as early 
as 1961 (O’Daly, 1961). Over 75% of the amino acid requirements (except phenylalanine) is 
provided in the form of a protein substitute. They also provide all tyrosine requirements. 
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presentation and composition of protein substitutes. 
They can be categorised into six groups: 
i 
ii 
iii 
iv 
V 
vi 
Protein hydrolysate powders - rarely used in the UK. 
Amino acid powders: ± carbohydrate, and without vitamins and minerals. 
Amino acid powders: with added vitamins and minerals but minimal carbohydrate. 
Amino acid powders: with added carbohydrate, ± fat, vitamins and minerals 
Amino acid capsules and tablets: without added carbohydrate, vitamins and minerals 
Amino acid bars: without vitamins and minerals. 
Their presentation and composition may affect phenylalanine control in 3 ways. Use of 
protein hydrolysate or L-amino acids as primary sources of protein equivalent may be 
inefficiently utilised and inadvertently affect control (Acosta, 1996); protein substitutes with 
added carbohydrate may reduce leucine oxidation and increase net protein synthesis (Motil et 
al 1981); and poor acceptability of taste or presentation may affect compliance and therefore 
phenylalanine control (Clark et al, 1994). The main types and features of protein substitute 
available in the UK are identified in Table 1.6. 
Requirements 
Insufficient protein substitute may affect phenylalanine control and growth. There is little 
available data to help assemble rational recommendations and therefore, there is much 
debate regarding requirements. In the UK, a high protein substitute intake is favoured and it 
is recommended that children under 2 years should take at least 3g/kg body weight/day; 
those over 2 years are recommended to take 2g/kg body weight/day. This is quite different to 
many centres in the USA and other European countries (Prince, McMurry, Buist, 1997; 
Schaeffer et al, 1994; Przyrembel 1996). 
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There is evidence that L-amino acids may be poorly utilised. Following ingestion of 
L-amino acids, with and without whole protein, there are higher and more rapid rises 
followed by more rapid declines in individual plasma amino acid concentrations than with 
whole protein alone (Gropper et al, 1993). This must inevitably lead to greater loss of amino 
acids both by destruction in the liver and excretion in the urine (Woolf, 1962). Indeed, it has 
been reported that nitrogen losses were significantly greater in subjects receiving L-amino 
acids as their source of protein equivalent than in subjects receiving the same amount of 
nitrogen from whole protein (Jones et al, 1983). 
In two independent PKU studies, Acosta and Yannicelli, (1 994) and Kindt et al, (1 984) have 
shown that phenylalanine tolerance increases when total protein intake from the protein 
substitute increases. Acosta et al, (1 994) demonstrated in 25 infants with PKU that when an 
infant protein substitute containing 3,12g of protein per 100 kcals was administered, the total 
daily phenylalanine intake increased and blood phenylalanine concentrations were lower than 
when a lower protein substitute was used. Kindt et al, (1 984) fed two groups of children 
with PKU different quantities of total protein. One group adhered to the US Recommended 
Dietary Amounts (RDA, 1980) and the other group to the lower safe levels recommended by 
the Joint FAO/WHO Expert Committee (1973). The RDA group tolerated 3-5 mg/kg body 
weight /day additional phenylalanine. Also, it was found that two children given the FAO 
safe level of protein had retarded growth velocity, and high fasting glycine and alanine amino 
acid values. This did not occur in the group of children fed the US RDA for protein. 
Furthermore, recent studies from Europe have reported impaired growth in infants and young 
children with PKU (Dhont et al, 1995; Schoeffer et al, 1994; Verkerk et al, 1994; 
Weglage et al, 1994) which could have been related to a low protein substitute intake. In 
the USA, Prince et al, (1997) found that in a group of patients aged 4-10 years the actual 
amino acid intake decreased from only 0.9 g/kg body weight/day to as little as 0.4 g/kg body 
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weight/day in children over 4.2 years of age. Growth and nutritional biochemistry were not 
adversely affected although mean serum phenylalanine increased from 380 to 480 mol/l. 
The authors suggested that the increase in serum phenylalanine was just a reflection of 
increasing patient age, but equally it could have related to reduced intake of protein 
substitute. 
Therefore, high quantities of protein substitute may lead to increased nitrogen retention 
(Kindt et al, 1984), improved phenylalanine tolerance (Acosta et al, 1994; Kindt et al, 1984), 
and help prevent an imbalance of amino acid transport across the blood brain barrier 
(Pratt, 1980). 
One study does not support a high intake of protein substitute. Clemens et al, (1 991) gave 
ten older patients aged from 15 to 37 years three different levels of protein from a standard 
phenylalanine free amino-acid mixture for three months each. This consisted of a) 1.5 g/kg 
of protein from a essential amino acids and tyrosine only; b) 0.75 g/kg from essential amino 
acids and tyrosine; and c) 0.65 g/kg of protein from essential amino acids and tyrosine. For 
all three levels of protein intake, there was no sign of amino acid imbalance or catabolism. 
On the basis of these results, Clemens suggested that providing a protein source of high 
biological value similar to the essential amino acid mix used in the study is given, the overall 
quantity of the protein substitute may be reduced (Clemens et al, 1991). However, all these 
patients were on more natural protein than younger children with PKU and intake varied 
between 9-26 g/day. Higher natural protein intakes should be taken into account when 
calculating protein substitute requirements. 
Timing of protein substitute intake 
The effect of timing of protein substitute intake on blood phenylalanine concentrations has 
not been systematically studied. It has been recommended that protein substitute should be 
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taken three times daily with main meals (Barnes, 1994). This is a demanding routine 
particularly in school-age children and adolescents. There is however, evidence that 
infrequent administration of large doses of protein substitute increases nitrogen excretion as 
well as oxidative utilisation of amino acids. In nine patients with PKU and one with 
hyperphenylalaninaemia, protein substitute was taken in one or two doses on day one, and on 
day two in three equal doses with meals (Schoeffer et al, 1994). In eight patients, excretion 
of nitrogen decreased from between 6.3-12.4g/day to 4.7-10.8g/day when the total amount 
of amino acid mixture was given in smaller and frerquent doses. Herrman et al, (1 994) 
demonstrated in a single subject with PKU, using the breath test to measure 
oxidative utilisation of a 33% dose of protein substitute produced 
elimination rate of 9.5% compared with 19.6% when protein substitute was 
given as a single larger dose. Evenly spread distribution of protein substitute intake may lead 
to better blood phenylalanine control, although there is no evidence to support this. 
1.7.2 Energy 
The importance of dietary energy in maintaining good blood phenylalanine control has not 
been demonstrated, though the influence of energy on protein utilisation and nitrogen 
balance is well documented (Millward and Rivers, 1987). In response to very low energy 
intakes net protein deposition is eliminated, and all dietary amino acids are oxidised. It is 
generally believed that the stimulation of tissue protein deposition occurs in response to 
intakes of dietary energy as well as protein, with dietary carbohydrate more effective than fat 
(Munro, 1964). Garza, Scrimshaw and Young (1 977) fed six subjects a diet providing the 
safe level of protein intake (0.57g/kg body weight) and showed they were unable to maintain 
nitrogen balance when their diet provided their calculated energy requirement. In fact, they 
were only able to maintain nitrogen balance when their energy intake was increased to such 
an extent they showed a persistent weight gain. It may be possible that an increase in energy 
intake in PKU may enhance net protein synthesis. However, the effect of this has not been 
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specifically studied in PKU, and there are no data which document the energy intake of PKU 
patients on the UK diet or have measured its effect on blood phenylalanine control. 
1.8 What do PKU children actually eat? 
There are potentially many other dietary factors which may affect blood phenylalanine 
control, However, it is difficult to assess the effect of any of these as there are no published 
data documenting macronutrient intake and timing of protein substitute intake in children 
with PKU in the UK. It is inappropriate to suggest dietary modifications until actual intake 
of children with PKU and effects on blood phenylalanine control are assessed. Moreover, 
there are few data describing dietary habits, food patterns, food preferences, utilisation of 
low protein special products and administration of protein substitute in PKU. It is important 
to understand fully the application and practices of diet therapy so that further advances can 
focus on what is tolerable, acceptable and practical for the patient. 
1.9 What is the effect of the PKU diet on normal eating 
behaviours? 
The low phenylalanine diet is perhaps one of the most difficult diet therapies designed for 
patients and parents. It is based on few normal foods, a limited number of low protein 
specialised products and an unpalatable protein substitute. Admittedly, children with PKU 
start this diet therapy shortly after birth, so should not develop a taste for normal foods, but 
their food looks and tastes very different from that for the rest of their family and friends. 
A PKU diet can be made appetising and acceptable, but this requires cooking skills, time, 
imagination, and a wide range of cooking appliances. There are no ready-made meals which 
can be purchased from supermarkets, so all meals have to be prepared from basic food 
ingredients. Some of the special low protein ingredients, such as the flour mixes, are very 
difficult to work with, as their basic structure as been altered by removing protein. As a 
consequence, low protein cooking failure rate appears high, which in turn leads to 
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disillusionment and the abandoning of low protein special cooking, except for the most 
dedicated of parents. Parents may then keep meals very simple and it is not uncommon for 
young children to be offered potatoes and vegetables only. Boredom, hunger and poor 
compliance may be the consequence. 
Food and mealtimes are an important feature of everyday life. Most of the food eaten by the 
rest of the family is unsuitable for a child with PKU and there may be a tendency to feed the 
child separately, so the family communication and rapport of mealtime is lost. In addition, 
the process of food shopping and preparation may not be shared with the child, which may 
lead to disinterest in their diet. Even cooking at school is based on normal food so there is 
little opportunity to learn about PKU cooking and diet. It is almost impossible to go for a 
meal in a cafe, restaurant or party and find food which is suitable. This means that children 
with PKU either have to take their own food, refrain from eating or even eat small amounts 
of forbidden food. 
It is, therefore, probable that such a restrictive diet therapy may adversely affect normal 
feeding behaviour particularly in young children. Surprisingly, no studies have investigated 
the effects of diet on feeding behaviour. There is a possibility that an over-restrictive diet 
and routine may adversely affect blood phenylalanine control either through lack of adequate 
calories or a rebellious child resorting to cheating. Therefore, it is important to measure the 
effect of this enforced, abnormal, diet on eating behaviour. 
1.10 Summary 
In PKU, intellectual and neurological outcomes are not as good as were first thought. These 
impairments are more closely linked with the quality of plasma phenylalanine control than 
previously recognised. This had led to recommendations that blood phenylalanine 
concentrations are kept lower and within narrower target ranges. There is some suggestion 
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that blood phenylalanine concentrations may undergo a wide diurnal variation, and it may be 
difficult to maintain blood phenylalanine concentrations which remain within target ranges. 
However, the evidence is limited and contradictory and circadian variation poorly 
understood. In addition, there is concern that the structure of the existing UK PKU diet may 
be incapable of achieving low, stable blood phenylalanine concentrations. Moreover, the 
PKU diet is complex and many factors may affect blood phenylalanine control, including 
allocation of dietary phenylalanine, contribution of phenylalanine from free foods, energy 
intake and timing and dosage of protein substitute intake. The effect of each of these factors 
on blood phenylalanine control has not been systematically studied. It is important that their 
impact on phenylalanine concentrations is documented before the diet can be modified and 
improved. Finally, the PKU diet is rigid, inflexible and can be unpalatable. If the diet is to 
be reconstructed or revised, it is essential that its effect on eating habits and feeding 
behaviour is established, to ensure it is tolerable and acceptable. 
1.1 1 Summary of questions addressed in PhD thesis 
1. Which dietary factors affect variation in plasma phenylalanine control in 
An observational, longitudinal study was conducted in well-controlled subjects with PKU to 
study the effect of three factors thought to influence plasma phenylalanine concentrations in 
PKU; total energy intake; protein intake from natural foods allowed freely in addition to 
allocated phenylalanine exchanges; and the distribution of protein substitute throughout the 
day. 
2. What is the effect of fruits and vegetables containing 1 - 100 mg 
PKU? 
phenylalanine on plasma phenylalanine control? 
This was studied in two parts: 
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1) A prospective, intervention, cross-over trial investigating the effect of protein versus 
phenylalanine analysis for dietary potato exchanges on blood phenylalanine control in 
PKU. 
2) A prospective, intervention, cross-over trial investigating the free use of fruits and 
vegetables containing 1-100 mg/100g of phenylalanine on blood phenylalanine control. 
3. What is the variation of blood phenylalanine concentration in PKU over 
24 hours and is a single blood phenylalanine concentration representative 
of a 24 hour period? 
An observational study was conducted investigating the 24 hour variability of plasma 
phenylalanine concentration in well-controlled in children with PKU. 
4. What is the effect of even distribution of protein substitute on blood 
It was hypothesised that administration of protein substitute over longer hours and in more 
frequent doses would lead to improved phenylalanine control. 
phenylalanine concentrations throughout the day and night? 
This was examined in a two part study: 
i) Part 1. A randomised, crossover study comparing three different protocols of protein 
substitute administration during the day in well-controlled subjects with PKU. 
ii) Part 2. A randomised, crossover study comparing three different protocols of protein 
substitute administration during both the day and night in well-controlled subjects 
with PKU. 
5. What is the effect of the PKU diet on normal eating behaviour? 
An observational, controlled study investigating the feeding behaviour of a group of 
unselected PKU children was conducted in a group of 15 PKU subjects aged 1-5 years old. 
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Chapter 2 
Factors affecting the variation in plasma 
phenylalanine in patients with phenylketonuria 
on diet 
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2.1 Introduction 
Many factors are thought to affect the day-to-day variation in plasma phenylalanine 
concentrations in PKU. They include additional or ‘hidden’ phenylalanine from ‘free’ foods, 
dietary energy, and timing of protein substitute intake. However, their impact on plasma 
phenylalanine concentrations has not been systematically studied, nor has the daily 
variability of each of these individual dietary components been investigated. 
The aims of this study were to assess the effects of plasma phenylalanine control of 
variations in phenylalanine intake from ‘free foods’, as well as the effect of total energy 
intake and the timing of protein substitute administration. In a longitudinal, observational 
study, the effects on dietary intakes on plasma phenylalanine concentrations were compared 
over six months in a group of well-controlled children with PKU. 
2.2 Methods 
2.2.1 Subjects 
Nineteen children with classical PKU were recruited. Eighteen were Caucasian and one 
Afio-Caribbean. There were three inclusion criteria: maintenance of plasma phenylalanine 
concentrations within the ranges recommended for age group by the MRC Working Group 
for 70% of the six month before entering the study; age 1 to 16 years; and parental ability to 
take skin puncture blood specimens at home by thumb prick. There were fifteen girls and 
four boys, with a median age of 6.6 years (range 1 to 16 years). All the children were on a 
strict low phenylalanine diet comprising: (1) a dietary phenylalanine allocation using a 50 
mg phenylalanine exchange system (50 mg 1 g protein); (2) a phenylalanine-free protein 
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substitute; and (3) low phenylalanine foods e.g. most fruits many vegetables and special low 
protein products, or so called “free” foods permitted in usual quantities. 
The median number of 50 mg phenylalanine exchanges allocated was five per day (range 3 
to 17), or 5g natural protein (Table 2.1). The following amounts of total protein/kg/body 
weight from protein substitute and phenylalanine exchanges were allocated: children 1 year 
of age, 3.0g/kg; 2-5 years, 2.5g/kg; 6-10 years, 2.0g/kg; over 11 years of age, 1.5g/kg. The 
brand of protein substitute used was chosen by the patient and was administered either as a 
paste or drink. Twelve patients used X P  Maxamaid (Scientific Hospital Supplies), three 
patients used Aminogran Food Supplement (UCB Pharma), three used Phlexy 10 Drink Mix 
(Scientific Hospital Supplies), and one used XP Maxamum (Scientific Hospital Supplies). I 
The study was approved by the Committee of Medical Ethics of South Birmingham Health 
Authority. Informed consent was obtained from all parents and from the patients (where 
maturity and understanding were appropriate). 
2.2.2 Methods 
Assessment of phenylalanine and energy intakes 
In total, parents performed serial 21-day weighed food intakes over 6 months at home. In 
months 1, 3, and 5 ,  parents weighed and recorded their child’s food intake over 3 days from 
Monday to Wednesday inclusive. In months 2,4, and 6, weighed food intakes were 
performed over 4 days from Thursday to Sunday inclusive. Parents recorded only food 
actually eaten, and any waste food was reweighed and deducted from the total weight. They 
also described cooking techniques, precise food brand, kept nutritional labels of 
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Table 2.1 
Age and allocated 50 mg phenylalanine exchanges of patients 
Patient No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
Age (years) 
3 
3 
12 
16 
7 
3 
1 
4 
2 
4 
1 
14 
9 
9 
16 
6 
9 
3 
3 
Sex 
(male/female) 
F 
F 
M 
F 
F 
F 
F 
F 
F 
F 
M 
F 
F 
F 
F 
M 
F 
M 
F 
Number per 
day of 50 mg 
phenylalanine 
exchanges 
5 
3 
8 
14 
5.5 
5 
7 
4 
3.5 
3 
3 
12 
3 
12.5 
17 
4 
9 
3.5 
3 
Recommended 
phenylalanine 
concentrations 
(MRC, 1993b) 
120-360 
120-360 
120-700 
120-700 
120-480 
120-360 
120-3 60 
120-3 60 
120-360 
120-3 60 
120-3 60 
120-700 
120-480 
120-480 
120-700 
120-480 
120-480 
120-360 
120-360 
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manufactured foods eaten, and identified individual ingredients of any home made dishes 
prepared. Parents were instructed to use Salter electronic scales. Immediately after each 
study period, parents were visited at home to check food records. Each meal and snack 
consumed by the child was reviewed with the parents to check accuracy. In addition, the 
weighing technique of each of the mothers was assessed and confirmed as adequate by 
weighing 10 different food items at the start of the study. Timing and quantity of protein 
substitute consumed were also recorded prospectively. 
Nutritional analysis of food intake was calculated using the Microdiet computer programme 
based on McCance & Widdowson’s “The Composition of Foods ” (Holland et al, 1991), with 
supplementary analysis data provided by the Royal Society of Chemistry (Holland et al, 
1991 a; Holland, Unwin, and Buss, 1991 b; Holland Unwin, and Buss, 1989; Holland, Unwin, 
and Buss, 1988). Additional information on protein substitutes and low protein special 
products was provided by manufacturers and added to the database. All food coding was 
done manually and entered into the computer by the same researcher. To minimise error, 
such as wrong amounts, incorrect codes, amounts or codes being entered twice, omitted data, 
transcription errors, all data codes were checked twice and a summary sheet of all food items 
for each day’s food diary was confirmed after the data had been entered into the computer. 
Excess natural protein intake was calculated in addition to the prescribed 1.0g protein (50 mg 
phenylalanine) exchanges. Energy intake was calculated as a percentage of the estimated 
average requirement for energy (EAR) (DH, 1991) and total protein intake as a percentage of 
reference nutrient intake (RNI). 
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The phenylalanine analysis was calculated from data from the First supplement to McCance 
& Widdowson s ” The Composition of Foods ” (Paul et al, 1980) and the Leatherhead Food 
Research Association and Laboratory of the Government Chemist (Weetch et al, 1997) fruit 
and vegetable phenylalanine analysis. When specific phenylalanine analysis data were not 
available it was assumed that 1 g protein yielded 50 mg phenylalanine (Barnes, 1994). 
Assessment of plasma phenylalanine concentrations 
Twice daily serial skin puncture (heel, finger or thumb) blood specimens for phenylalanine 
were taken at home on the same days as the weighed food intake. Blood specimens (300 
were taken at the same time each day, standardised for each patient, but always pre-breakfast 
and pre-evening meal. The blood specimens were collected in Starstedt CB300 heparinised 
tubes by parents and immediately posted to the hospital laboratory to arrive within 24 hours 
of collection. Blood collection technique had been taught and competence assessed by a 
specialist nurse. All patients were free from intercurrent infections on the days of the study. 
If a patient became ill immediately before or during the study days, the plasma phenylalanine 
measurements and weighed food intake were deferred until the patient had recovered. 
Blood specimens were analysed for phenylalanine by high pressure liquid chromatography 
(HPLC) (Atherton and Green, 1988) in the Birmingham Children’s Hospital screening 
laboratory. Specimens were centrifuged on receipt, and the plasma was removed and stored 
frozen (-20°C) if it was not analysed without delay. 
The plasma was precipitated in 50 -aliquots of equal volumes of plasma and perchloric 
acid containing an internal standard of alpha-methyl phenylalanine. The supematant was 
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frozen to enhance protein precipitation and then centrifuged. The supernatant was then 
injected using an auto-sampler onto the HPLC with an aqueous calibration curve. Internal 
quality control specimens were processed identically. The phenylalanine and internal 
standard were detected by their absorption of ultra-violet light at a wavelength of 214 nm. 
The phenylalanine concentrations were calculated by the comparison of its absorption with 
those of calibrating standards. The assay quality was checked by the National External 
Quality Assurance Scheme. 
2.3 Statistical analyses 
Statistical analysis was by Pearson Product Moment Correlation Coefficient (r) when 
comparing intake of dietary protein from ‘freely’ allowed foods, timing of protein substitute, 
and energy intake on plasma phenylalanine concentrations. Paired t tests were used to 
compare pre-breakfast and pre-evening plasma phenylalanine concentrations and natural 
phenylalanine and protein intake. Multiple regression was used to compare the effect of 
intake of dietary protein from ‘freely’ allowed foods, timing of protein substitute and energy 
intake on change in plasma phenylalanine concentrations between pre-breakfast and pre- 
evening meal. 
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2.4 Results 
2.4.1 Dietary intake 
protein intake 
Natural protein intake 
Assuming that 1.0g protein is equivalent to 50 mg of phenylalanine, the allocated median 
daily natural protein intake was 5g (range 3-17g), although the actual was 7.8g (range 
4.1-21.5g) daily. A comparison of prescribed protein intake with actual intake (derived 
from weighed food results) showed that patients consumed a mean (SD; range) of 
49% (37%, 12-1 62%) extra natural protein from phenylalanine exchanges to the prescribed 
amount. Only a mean of 6% (SD 9.5) of the excess protein was from miscalculation of 
phenylalanine exchanges by the parents. There was a very large day-to-day variation for 
some patients (Fig 2.1) with a mean (SD; range) coefficient of variation of 60% (32%; 
1 1-1 50%) for the entire group of patients. There was no correlation with age. The median 
natural protein intake was distributed as follows: 27% breakfast and pre-midday; 27% lunch 
and pre-evening meal; and 45% pre-evening meal and bedtime. The five most common 
sources of natural protein were crisps, breakfast cereal, potatoes, chips and tinned spaghetti. 
Actual phenylalanine intake 
Using phenylalanine analysis data, and when unavailable, extrapolating phenylalanine 
analysis from protein analysis, the actual phenylalanine intake was a median of 330 mg daily 
(range 170-1,000 mg). This equates to 6.6g (range 3.4-20g) natural protein daily and was 
significantly less than actual protein intake (p <0.0001), but still more than allocated 
5 1  
phenylalanine exchanges by a mean of 31% (SD 32, range -9 to 113%). However, there was 
close correlation between actual protein and phenylalanine intake 
(r = 0.975; p <0.0001) (Fig 2.2). The mean (SD; range) coefficient of variation of 
i 
phenylalanine intake was only 20% (6%; 8 to 31%) which was less variable and lower when 
compared to dietary protein (p <0.0001) (Fig 2.3). Although phenylalanine per 
kg/bodyweight decreased with age, the correlation was not significant (p = 0.0668). 
Protein intake from protein substitute 
The median protein intake from protein substitute was 36g (range 13-668) daily. The 
median percentage of protein from protein substitute was 84% (range 49-87%). Only two 
patients reported that they did not consistently complete the protein substitute. 
Total protein intake (from natural protein and protein substitute) 
The median total daily protein intake was 43g (range 33-76g) daily, or 2.3g/kg/day (range 
1-3.6g/kg/day). It provided a median intake of 201% (range 133-296%) of the dietary 
reference value for protein (DH, 1991). 
Timing of protein substitute intake 
Although patients were advised to consume the protein substitute in equal amounts three 
times daily, at set times with meals, actual practices varied considerably. For at least 80% of 
the study, only 37% of the patients took the protein substitute three times daily at mealtimes, 
42% took it twice daily at breakfast and with the evening meal, and 21% took all the protein 
substitute in the morning or in the evening. Twenty six percent of these patients varied the 
timing for a small number of the study days. 
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Energy intake 
Patients had a mean (SD, range) energy intake of 105% (17%, 77-1 78%) of the DH (1991) 
estimated average requirements. The median intake per kg was 80 kcal 
(range 25-157 kcal/kg/day) which decreased with age (p <0.0001) (Fig 2.4). The median 
day to day variability was only 16% (range 11-30%) (Fig 2.5). The energy intake was 
distributed throughout the day as follows: 29% breakfast and pre-midday; 36% lunch and 
pre-evening meal and 35% evening meal and bedtime. The five chief dietary energy sources 
were crisps, low protein bread, cereal, liquid Duocal (Scientific Hospital Supplies), 
margarine and butter. Twenty seven percent (range 7-58%) of the energy was provided by 
the protein substitute. 
The mean energy intake of each of the subjects correlated positively (r = 0.4404) with excess 
protein intake from free foods, i.e. patients who had a better appetite and consumed more 
energy from free foods, had a higher excess natural protein intake. This did not reach 
statistical significance (p = 0.0591) (Fig 2.6). Furthermore, there was a weak negative 
correlation (r = -0.309) between timing of protein substitute intake and total energy intake. 
The total energy intake appeared to be lower when patients had a higher proportion of their 
daily protein substitute before the evening meal. This did not reach statistical significance 
(Fig 2.7). 
Fat intake 
The overall fat intake was low. The median daily intake was 44g (range 18-91g) or 
1.9g/kg/day (range 0.5-6g/kg/day). It provided a median of only 23% (range 16-35%) of 
the energy intake. Day to day fat intake varied more widely than energy, with a median 
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The total energy intake appeared to be lower when patients had a higher proportion of their 
daily protein substitute before the evening meal. This did not reach statistical significance 
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Fat intake 
The overall fat intake was low. The median daily intake was 44g (range 18-91 g) or 
1.9g/kg/day (range 0.5-6g/kg/day). It provided a median of only 23% (range 16-35%) of 
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coefficient of variation of 30% (range 17-50%) (Fig 2.8). The daily fat intake was 
distributed as follows: breakfast and pre-midday 29%, lunch and pre-evening meal 42%; 
evening meal and bedtime 32%. The five most common fat sources in the diet were crisps, 
butter, margarine, liquid Duocal (Scientific Hospital Supplies) and Calogen (Scientific 
Hospital Supplies). The protein substitute contributed almost no dietary fat, with the 
exception of one child who took part of his protein substitute requirements from the infant 
product, X P  Analog (Scientific Hospital Supplies). 
Carbohydrate 
The carbohydrate intake was high. The median daily intake was 249g (range 150-4238) 
daily, or 13,2g/kg/day (range 4-23g/kg/day). It provided 59% (range 53-69%) of the energy 
intake. The median daily coefficient of variation was only 17% (range 10-29%) (Fig 2.9). 
It was fairly evenly distributed throughout the day; 30% breakfast and pre-midday; 34% 
lunch and pre-evening meal; and 36% evening-meal and bedtime. The protein substitute 
supplied over a quarter of the carbohydrate intake: median intake of 27% (range 0-64%). 
Other important dietary carbohydrate sources include: low protein bread, breakfast cereals, 
super soluble Maxijul (Scientific Hospital Supplies), potatoes and crisps. 
Alcohol 
Only one patient consumed alcohol on two occasions. It contributed a mean of 1% 
(SD 3.2) of total energy intake for this patient. 
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2.4.2 Blood phenylalanine results 
Variation between plasma phenylalanine concentrations in early morning and 
late afternoon blood specimens 
For some patients, there was considerable variability between day-to-day early morning and 
late afternoon plasma phenylalanine concentrations: plasma phenylalanine, mean a.m. 282 
mol/l (SD 162) (Fig 2.10); mean p.m. 243 mol/l (SD 184) (Fig 2.11). Although there was 
a Significant decrease between mean early morning and late afternoon plasma phenylalanine 
concentrations (p = 0.012) there was a widespread variation in the change between early 
morning and late afternoon concentrations: mean plasma phenylalanine change -40 mol/l 
(SD 62) (Fig 2.12). Thirty per cent (n = 107) of all morning plasma phenylalanine 
concentrations increased between early morning and late afternoon. 
Effect of dietary phenylalanine intake from freely allowed foods on plasma 
phenylalanine concentrations 
For almost all patients there was no significant within-subject correlation between excess 
natural protein intake or total protein intake and (1) pre-breakfast or pre-evening meal 
plasma phenylalanine concentrations; or (2) daily change between pre-breakfast and pre- 
evening meal plasma phenylalanine concentrations. Similarly there was no significant 
correlation between excess natural protein intake on the previous day and plasma 
phenylalanine concentration on the following morning (Table 2.2) 
Effect of energy intake on plasma phenylalanine concentrations 
For the majority of patients there was no significant correlation between energy intake and 
(1) pre-breakfast or pre-evening meal plasma phenylalanine concentrations; or (2) the 
difference between pre-breakfast and pre-evening meal plasma phenylalanine concentrations. 
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Table 2.2. Effect of excess percentage protein intake from freely allowed foods on 
Nor was the previous day’s energy intake significantly related to the following morning’s 
plasma phenylalanine concentration (Table 2.3). 
Effect of timing of protein substitute on plasma phenylalanine concentrations 
The timing of protein substitute ingestion had a major impact on changes in plasma 
phenylalanine concentration. There was a strong negative correlation between the amount of 
protein substitute taken by the time of the evening meal and the change in plasma 
phenylalanine concentrations during the day (r = 0.941, p <0.0001) (Fig 2.13). The more 
protein substitute taken early in the day, the greater the fall in plasma phenylalanine 
concentrations during the course of that day. On the basis of recommendations that children 
with PKU take the protein substitute three times daily with meals, it can be expected that 
patients should have taken at least 65% of it by the evening meal. In children who had taken 
more than 65% of their protein substitute by the time of their evening meal, almost half 
(49%) of pre-evening meal plasma phenylalanine concentrations were less than 100 mol/l. 
Conversely, the less the protein substitute taken before the evening meal, the higher the 
increase in plasma phenylalanine concentrations during the day. 
There was a positive correlation between the quantity of protein substitute taken by the time 
of the evening meal and the overnight change in plasma phenylalanine concentrations which 
subsequently took place between the pre-evening meal and the following pre-breakfast 
samples (r = 0.8724, p <0.0001) (Fig 2.14). 
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Multiple regression analysis 
Using multiple regression analysis, the effect of change in morning to evening plasma 
phenylalanine concentrations of all 3 variable factors i.e.: (1) timing of protein substitute intake, 
(2) dietary phenylalanine intake from freely allowed foods and (3) energy intake were 
compared. (Table 2.4) 
Table 2.4 
Multiple regression analysis: Factors affecting variability in blood phenylalanine 
concentrations 
R-squared = 89.7% R-squared (adjusted = 87.6%) 
This confirmed that the only factor, which significantly correlated with change in plasma 
phenylalanine concentrations between a.m. and p.m., was timing of protein substitute intake. 
Using stepwise regression, when the effect of energy intake was removed from the equation, the 
effect of dietary phenylalanine from freely allowed food changed only slightly (regression 
coefficient = -0.2258; SD 0.1473; t - ratio -1.53; p= 0.145). 
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2.5 Summary 
This study shows large diurnal fluctuations ir. plasma phenylalanine concentrations in a group of 
patients who had been carefully selected on the basis that they maintained routinely taken 
plasma phenylalanine concentrations within ranges recommended by the MRC working group. 
Furthermore, it shows that blood samples pre-breakfast plasma phenylalanine concentrations 
were not always higher than in the evening. The MRC report recommended that blood 
specimens should be taken in the early morning when plasma concentrations were considered to 
be at a peak. 
This study also shows that ‘free’ low protein foods contribute a significant quantity of additional 
excess protein and phenylalanine. It demonstrates a large day-:+day variation in natural protein 
intake. However, plasma phenylalanine concentrations were strongly influenced by the timing 
of the protein substitute, but not by total energy or excess natural protein intake from ‘freely’ 
allowed foods. Patients who had taken 65% or more of their protein substitute by the time of 
their evening meal showed a fall in plasma phenylalanine concentration during that day. In 
contrast, patients who delayed most or all of their protein substitute until after their evening 
meal showed a rise in plasma phenylalanine concentration during the day. Patients who took 
their protein substitute in two doses evenly distributed between morning and evening showed 
little variation in their plasma phenylalanine concentrations. For the study group overall, there 
was significantly greater variability in evening plasma phenylalanine concentrations than for 
morning concentrations. 
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Chapter 3 
A prospective, cross-over trial assessing the 
impact of new potato exchange allowances on 
blood phenylalanine concentrations in PKU 
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3.1 Introduction 
potato is one of the most commonly used 50 mg phenylalanine exchanges in PKU. Some 
children have 20-50% of their daily phenylalanine from this source. Traditionally, 
phenylalanine exchanges are extrapolated from total protein content rather than the 
phenylalanine content of foods. It is assumed that 1 g protein yields 50 mg phenylalanine 
(Barnes, 1994). In 1996, the phenylalanine content of a number of varieties of potato 
prepared in different ways, were analysed (Weetch, 1997). Overall phenylalanine content 
was much lower than in previously published reports. On average, one gram of protein 
yielded only 28 mg phenylalanine for potatoes. As a consequence, the phenylalanine 
exchanges for potato have been revised and are now based specifically on phenylalanine 
data. This has resulted in the quantity of potato allocated for phenylalanine being almost 
doubled. 
As potato is such a staple food in the PKU diet, it is possible that allowing the higher 
amounts of potato for phenylalanine exchanges may change blood phenylalanine 
concentrations. We therefore compared plasma phenylalanine concentrations in a group of 
subjects following the use of potato exchanges based on old or revised criteria. 
3.2 Subjects and methods 
3.2.1 Subjects 
Sixteen subjects (1 5 Caucasian, 1 Afro-Caribbean) were recruited into the study. There were 
14 girls and 2 boys with a mean age of 7 years (1-24 years). All had classical PKU. There 
were four inclusion criteria: i )  maintenance of at least 70% plasma phenylalanine 
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concentrations (weekly, fortnightly or monthly according to age group) within ranges 
recommended by the MRC Working Group (1 993) in the 6 months before entering the study; 
2) age over 1 year; 3) ability to eat prescribed quantity of potato; and 4) demonstrable 
parental ability to take skin puncture blood specimens at home. 
The median number of 50 mg phenylalanine exchanges was 6 daily (range 4 to 16). The 
following amounts of total protein from protein substitute and phenylalanine exchanges were 
allocated: age <2 years: 3.0g/kg/day; 2 - 5 years: 2.5g/kg/day; 6 - 10 years: 2.0g/kg/day; 
over 11 years of age: I.5g/kg/day. Patients were given their usual brand of protein 
substitute. This was taken either as a paste or drink. Nine patients used XP Maxamaid 
(Scientific Hospital Supplies), five used Phlexy 10 Drink Mix (Scientific Hospital Supplies), 
one used Aminogran Food Supplement (UCB Pharma) and one used XP Maxamum 
(Scientific Hospital Supplies). 
This study was approved by the Committee on Medical Ethics of South Birmingham Health 
Authority. Informed consent was obtained from all parents and competent patients. 
3.2.2 Study design 
This was an 8-week, open, prospective crossover study conducted at home (Fig 3.1). During 
the first 3 weeks, subjects ate at minimum of one potato 50 mg phenylalanine exchange daily 
using phenylalanine data extrapolated from protein content (Table 3.1). During weeks 4 to 
8, subjects ate a minimum of one potato 50 mg phenylalanine exchange daily using the new 
phenylalanine content. Over the last 3 days on weeks 1 ,3 ,6  and 8, twice-daily serial skin 
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blood specimens were collected at the same time each day, standardised for each patient, but 
50 mg phenylalanine 
Type of Phenylalanine Protein exchange weight (g) 
potatoes mg/l00g¹ g/100g² based on protein 
content' 
Boiled 44 1.8 55 
potatoes 
Nicola boiled 70 1.8 55 
potatoes 
Mashed 43 1.8 55 
potatoes 
Jacket potato 62 3.9 25 
with skin 
Chips 108 3.2 25 
Roast potato 88 2.9 35 
always pre-breakfast and pre-evening meal. 
Average 50 mg 
phenylalanine 
exchange weight (g) 
based on 
phenylalanine 
content4 
80 
80 
80 
80 
45 
55 
Table 3.1 Estimated and directly measured phenylalanine content of potatoes 
1. Weetch et al, 1997 
2. Holland et al, 1991 
3 .  NSPKU, 1994 
4. NSPKU, 1998 
On the same days that the blood specimens were taken, subjects followed the same standard 
menu which was individualised for each patient. This was a repeat of the food intake which had 
been eaten on the last three days of week 1, but with the addition of the increase in weight of the 
potato exchanges, based on the new phenylalanine content, during weeks 6 and 8. All food 
intake was weighed and recorded on blood sampling days. 
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Assessment of plasma phenylalanine concentrations 
parents or subjects took heel or thumb skin puncture blood specimens at home, and immediately 
posted them to the hospital. Blood collection technique had been taught and competence 
assessed by a specialist nurse. All blood specimens were centrifuged upon receipt and resulting 
plasma samples stored at -20°C until analysed. Plasma phenylalanine concentrations were 
measured by HPLC as previously described. 
Assessment of dietary intake 
Throughout the entire study, parents or subjects kept a daily diary of all potato exchanges eaten. 
After week 1, on blood sampling days, the only food and drinks parents or carers were 
instructed they could vary were very low phenylalanine foods (containing <0.3g/100g of 
protein), such as sweets and squash drinks. They were instructed to keep to standard times for 
administration of protein substitute on these days. All food and drink consumed was weighed 
using Salter scales (accurate to 5g), about which parents or older subjected had been instructed. 
Only food and drink actually consumed was recorded; any remaining food was deducted from 
the start weight. 
Protein and nutritional analysis of food was calculated using the Microdiet computer programme 
based on McCance & Widdowson’s “The Composition of Foods ” (Holland et al, 1991), with 
supplementary analysis data provided by manufacturers and added to the data base as previously 
described in chapter 2. Phenylalanine analysis of potatoes was based on data from the 
Leatherhead Food Research Association/Laboratory of the Government 
81 
Chemist in London (Weetch et al, 1997). Energy intake was calculated as a percentage of the 
estimated average requirement for energy (DH, 1991). 
3.3 Statistical analyses 
Statistical analyses were by paired t tests and by a general linear model analysis of variance to 
compare differences using potato exchanges derived either from protein content or from direct 
phenylalanine content. 
3.4 Results 
There was no significant difference between pre-breakfast and pre-evening meal plasma 
phenylalanine concentrations when 50 mg phenylalanine exchanges for potato extrapolated from 
either protein or phenylalanine content were used. 
3.4.1 Dietary intake 
Subjects consumed a median extra 27 mg phenylalanine (an increase of 10%) and 1.0g natural 
protein (an increase of 18%) daily (Fig 3.2), when the new potato exchanges based on direct 
phenylalanine measurement were eaten. In addition, dietary energy (p <0.005) (Fig 3.3), 
fat (p <0.05) (Fig 3.4) and carbohydrate (p <0.001) (Fig 3.5) all significantly increased, which 
was entirely due to the new potato exchanges which were boiled, mashed or fried (Table 3.2). 
Subjects consumed a median intake of 14 (range 7-29) potato exchanges per week in both 
weeks 1-3 and weeks 4-8. 
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3.4.2 Plasma phenylalanine concentrations 
There was no significant difference between mean pre-breakfast plasma phenylalanine 
concentrations between weeks 1-3 (mean 336 SD 213) and weeks 4-8 (mean 
322 SD 211) (Fig 3.6). Equally, there was no difference between pre-evening meal 
plasma phenylalanine concentrations between the same two study periods (mean plasma 
phenylalanine:- weeks 1-3: mean 309 SD 234; weeks 4-8: mean 310 SD 233) 
(Fig 3.7). The median (range) change in pre-breakfast and pre-evening meal plasma 
phenylalanine concentration between weeks 1-3 and weeks 6 - 8 was -4 (-227 to 100 
and 36 (-283 to 134 respectively (Fig 3.8). 
3.5 Summary 
This study provides clear evidence that the new phenylalanine content can be safely used for 
potato exchanges in PKU. This is despite a median increase in phenylalanine intake of 27 mg 
daily. Previous analysis, extrapolated from the protein content of potatoes, overestimated the 
phenylalanine content, thus reducing the portion size for these staple foods in PKU. Thus, the 
new phenylalanine analysis data for potatoes has allowed relaxation in this difficult and rigid 
diet. 
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Chapter 4 
A prospective, cross-over trial investigating the 
effect of free use of fruit and vegetables 
containing intermediate amounts 
(51-100 mg/100g) of phenylalanine on control 
in PKU 
93 
4.1 Introduction 
There is no rational approach to the allocation of fruit and vegetables containing phenylalanine 
between 51-100 mg/100g in the PKU diet. Some are incorporated as part of the 50 mg 
phenylalanine exchange system; others are freely allowed in the diet without measurement. 
In chapter 2, the study examining factors affecting variation in plasma phenylalanine 
concentrations demonstrated that natural protein was increased by almost 50% from mainly 
‘free’ foods, such as fruit and vegetables but this did not destabilise overall control. That study 
included some of the permitted vegetables containing intermediate amounts of phenylalanine 
(51-100 mg/100g) freely, but others were counted as exchanges. It is possible that all fruit and 
vegetables containing 51-100 mg/100g of phenylalanine could be permitted freely in the PKU 
diet. However, their free use has not been investigated. The aim of this study was to 
systematically evaluate the effect of the free use of fruit and vegetables containing 
phenylalanine between 51-100 mg/100g on patients with PKU. 
4.2 Subjects and methods 
4.2.1 Subjects 
Seventeen subjects (16 Caucasian, 1 Afio-Caribbean) were recruited into the study. There were 
15 girls and 2 boys with a median age of 6 years (range 1-24 years). All had classical PKU. 
There were four inclusion criteria: 1) maintenance of at least 70% plasma phenylalanine 
concentrations (weekly, fortnightly or monthly according to age group) within ranges 
recommended by the MRC Working Group (1 993) in the 6 months before entering the study; 
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2) age over 1 year; 3) ability to eat fruit and vegetables containing phenylalanine either between 
50-75 mg/100g or 76-100 mg/100g; 4) demonstrable parental ability to take skin puncture 
blood specimens. 
Part 1 and 2: Fruit and vegetables containing phenylalanine between 
51-75 mg/100g 
Fifteen subjects (13 girls; 2 boys) entered this part of the study. Their median age was 6 years 
(range 2-24 years), and their median daily intake of 50 mg phenylalanine exchanges was 6 
(range 5-16). Three patients did not continue to complete part 3 of the study, as they disliked 
the vegetables in this category. 
Part I ,  2, and 3: Fruit and vegetables containing phenylalanine between 
76-100mg/100g 
Fourteen subjects (12 girls and 2 boys) entered this part of the study. Their median age was 6 
years (range 1-19 years) and their median daily intake of 50 mg phenylalanine exchanges was 6 
(range 5-16). Two subjects omitted weeks 4-8 of part 2 of the study as they disliked these fruit 
and vegetables but continued part 3. 
All patients were eating 50 mg phenylalanine potato exchanges based on phenylalanine content 
rather than calculated from protein analysis. The following amounts of total protein from 
protein substitute and phenylalanine exchanges were allocated: 
age <2 years: 3.0g/kg/day; 2-5 years: 2.5g/kg/day; 6-10 years: 2.0g/kg./day; over 11 years of 
age: 1.5g/kg/day. Patients were given their usual brand of protein substitute. This was taken 
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either as a paste or drink. Ten patients used X P  Maxamaid (Scientific Hospital Supplies), and 
five used Phlexy 10 Drink Mix (Scientific Hospital Supplies), one used PKU Aid 4 (Scientific 
Hospital Supplies), and one used XP Maxamum (Scientific Hospital Supplies). 
This study was approved by the Committee on Medical Ethics of South Birmingham Health 
Authority. Informed consent was obtained from all parents and all competent patients. 
4.2.2 Study design 
This was a three-part, open, prospective, cross-over study conducted at home. The free use of 
fruits and vegetables containing phenylalanine between 0-50 mg/100g, 51-75 mg/100g and 
76-100mg/100g mg was studied sequentially. Patients could take part in two or all three parts 
of the study. This was determined by their ability to eat the different fruit and vegetables 
under study. 
Part 1: Fruit and vegetables containing phenylalanine 0-50 mg/100g 
During weeks 1-3, subjects ate only fruit and vegetables containing phenylalanine 
<50 mg/100g freely. Twice daily serial skin puncture blood specimens for plasma 
phenylalanine were collected over the last 3 days on weeks 1 and 3. Specimens were always 
collected pre-breakfast and pre-evening meal. They followed the same standard menu on blood 
sampling days in week 3 as eaten in week 1. 
Part 2: Fruit and vegetables containing phenylalanine 51-75 mg/100g 
During the weeks 4-8, subjects ate at least one portion daily of fruits and vegetables containing 
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phenylalanine 51-75mg/100g as free food. This included foods such as bananas, mushrooms 
g/100g 
2.1 
1.2 
and raisins (Table 4.1). 
free 
100g/exchange 
Table 4.1 
Protein and phenylalanine content of fruit and vegetables containing 
phenylalanine between 51-100 mg/100g 
Phenylalanine 
51-75mg/100g 
Raisins 
Banana 
Leeks 
Sultanas 
Mushrooms 
Mange tout 
Avocado 
Mushrooms, fried 
Phenylalanine 
76-100mg/100g 
Broccoli 
Asparagus 
Cauliflower 
Brussels sprouts 
Beansprouts 
Yam 
Phenylalanine 
mg/100g 
Protein I Current Status I 
51 
53 
0.7 
2.7 
1.8 
3.2 
1.9 
84 
89 
92 
93 
97 
free 
free 
free 
30g/exchange 
55g/exchange 
3.4 
2.9 
2.9 
2.9 
1.7 
1 servingiday 
35g/exchange 
1 serving day 
60g/exchange 
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A portion was defined as that containing at least 20g of fruit and vegetable. Twice-daily serial 
skin puncture blood specimens were always collected pre-breakfast and pre-evening meal over 
the last 3 days on weeks 6 and 8. They also followed the same standard menu on blood 
sampling days as week 1, but during weeks 6 and 8 at least one portion of fruit and vegetable 
containing phenylalanine between 51-75 mg/100g was added to the menu. 
Part 1,2, and 3: Fruit and vegetables containing phenylalanine 
76-100 mg/100g. 
Continuing from the first two parts of the study, subjects consumed 3 portions per week of 
vegetables containing phenylalanine between 76-100 mg/100g for a further 7 weeks (Table 4.1). 
A portion was defined as that containing at least 20g of vegetable. Over the last 3 days of weeks 
11, 13 and 15, additional twice daily serial skin puncture blood specimens were taken pre- 
breakfast and pre-evening meal. They followed the same standard menu as for week 1, but also, 
when possible, continued to eat fruits and vegetables containing phenylalanine between 51-75 
mg/100g on blood sampling days. They also consumed at least one portion daily of vegetables 
containing phenylalanine between 76-100 mg/100g on blood sampling days. 
Assessment of plasma phenylalanine concentrations 
Parents or subjects took heel and thumb skin puncture blood specimens at home, and 
immediately posted them to the hospital. Blood collection technique had been taught and 
competence assessed by a specialist nurse. All blood specimens were centrifuged upon receipt 
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and resulting plasma samples stored at -20°C until analysed. Plasma phenylalanine 
concentrations were measured by HPLC as previously described. 
All patients were free of intercurrent infections on the days of the blood sampling. If a subject 
became ill immediately before or during blood sampling days, the plasma phenylalanine 
measurements and standard menu were deferred until the patient had recovered. 
Assessment of dietary intake 
Throughout the study, parents or subjects kept a diary of any fruit and vegetables eaten 
containing phenylalanine between 51-75 mg/100g or 76-100 mg/100g. On blood sampling 
days, the only food and drink parents or carers were instructed they could vary were very low 
phenylalanine foods (containing <0.3g/100g of protein) such as sweets and squash drinks. They 
were also instructed to keep to the same times for administration of protein substitute on these 
days. All food and drink was weighed using Salter scales (accurate to 5g), about which parents 
or older subjects had been instructed. Only food and drink actually consumed was recorded; 
any remaining food was deducted from the total start weight. 
Nutritional analysis was calculated using the Microdiet computer programme based on 
McCance & Widdowson’s “The Composition of Foods ” (Holland et al, 1991), with 
supplementary analysis data provided by manufacturers and added to the data base as previously 
described in chapter 2. Phenylalanine analysis of fruit and vegetables was based on data from 
the Leatherhead Food Research Association and Laboratory of the Government Chemist in 
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London (Weetch, 1997). Energy intake was calculated as a percentage of the estimated average 
requirement for energy (DH, 1991). 
4.3 Statistical analyses 
Statistical analyses was by paired t tests to compare differences between weeks 1-3 and 4-8, 
and weeks 1-3 and 9-1 5. Repeated Measures Analysis of Variance, and Tukey-Kramer Multiple 
Comparison Test were used to compare differences between each part of the fruit and vegetable 
study, i.e. weeks 1-3, 4-8 and 9-15. 
4.4 Results 
4.4.1 Part 1 and 2: Addition of fruit and vegetables containing phenylalanine 51- 
75mg/100g 
The free use of fruit and vegetables containing phenylalanine between 51-75 mg/100g did not 
adversely affect plasma phenylalanine control. There was no significant difference in pre- 
breakfast plasma phenylalanine concentrations between weeks 1-3 (mean: 318 SD 175) 
when only fruit and vegetables containing phenylalanine <50 mg/100g were given and 
weeks 4-8 (mean: 312 SD 196), when at least one portion of fruit and vegetable 
containing phenylalanine between 51-75mg/100g was given daily (Fig 4.1). Nor was there any 
difference in pre-evening meal plasma phenylalanine concentrations between the study periods 
(mean plasma phenylalanine:- weeks 1-3: 273 SD 184; and weeks 4-8: 282 
SD 222) (Fig 4.2). 
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Subjects ate an extra medium of 51 mg (range 30-1 38mg) of phenylalanine daily from fruit and 
vegetables containing phenylalanine between 51-75 mg/100g on the days of dietary assessment 
(Fig 4.3). This increased phenylalanine intake by a median of 15% (range 5-55%) over 
allocated exchanges (Fig 4.3). An additional median of 1.3g protein (range 0.7-3.2g) daily 
came from this source and excess protein over allocated exchanges from all free foods increased 
from a mean of 46% (SD 27) in weeks 1-3 to 68% (SD 30) in weeks 4-8 (p <0.0001) (Fig 4.4). 
Natural protein (p <0.005) (Fig 4 .9 ,  energy (p <0.001), (Fig 4.6) and carbohydrate (p <0.005) 
(Fig 4.7), but not fat intake significantly increased between weeks 1-3 and 4-8 (Table 4.2). 
The mean % EAR for energy (weeks 1-3: 94.8%, SD 16.3; weeks 6-8: 99.9%, SD 17.7; 
p <0.001) and the RNI for protein (weeks 1-3: 256%, SD 56; weeks 6-8: 265%, SD 61; 
p <0.0001) also significantly increased with the addition of fruit and vegetables containing 
phenylalanine between 51-75 mg/100g. This was entirely due to the protein and carbohydrate 
in the fruit and vegetables sources. The percentage energy provided by protein (p <0.05) and fat 
(p <0.05) decreased slightly but this was significant; the percent energy provided by 
carbohydrate increased but this was not quite significant (p <0.09). The median daily weight of 
fruit and vegetables containing phenylalanine between 51-75 mg/100g consumed was 83g 
between weeks 4-8. 
4.4.2 Part 1, 2 and 3: Addition of fruit and vegetables containing phenylalanine 
76-100mg/100g 
The free addition of vegetables containing phenylalanine between 76-100 mg/100g freely in the 
diet did not destabilise blood phenylalanine control. There was no significant difference in pre- 
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Table 4.2 
Nutrient intake during the study 
103 
breakfast plasma phenylalanine concentrations between weeks 1-3 when no fruit and vegetables 
containing phenylalanine between 51-100 mg/100g were eaten (mean plasma phenylalanine: 
326 SD 183); and in weeks 9-15 when three portions were eaten each week (mean 
plasma phenylalanine 272 SD 199) (Fig 4.8). Nor was there any difference in pre- 
evening meal plasma phenylalanine concentrations between the study periods (mean plasma 
phenylalanine:- weeks 1-3: 274 (SD 193); weeks 4-8: 273 (SD 208); 
weeks 9-15: 270 (SD 204)) (Fig 4.9). 
The vegetables containing phenylalanine between 76-100 mg/100g increased phenylalanine 
intake by a median of 39 mg daily (range 13-143 mg) (Fig 4.10). Overall, the protein intake 
provided by all ‘free’ foods in excess of allocated exchanges increased from 46% between 
weeks 1-3 to 64% between weeks 4-8 and 86% between weeks 9-15 (weeks 1-3 vs 
rest p <0.001) (Fig 4.11). Although total protein (p <0.005) significantly increased, 
carbohydrate only slightly improved and fat intake remained unchanged (Table 4.2) between 
weeks 1-15. There was no significant change in the distribution of energy between 
carbohydrate, fat and protein. The median portion size of vegetables containing phenylalanine 
between 76-100mg consumed was 50g (10-150g) at least 3 times weekly from weeks 9 - 1 5 .  
4.5 Summary 
This study demonstrates that fruit and vegetables containing between 51-100 mg of 
phenylalanine did not adversely affect control when permitted without restriction in PKU. They 
provided a substantive source of dietary phenylalanine; increasing daily phenylalanine by a 
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median of 51 mg and 39 mg respectively in the two test periods. Their lack of apparent affect 
on blood phenylalanine concentrations is surprising. However, satisfactory portion sizes were 
tested over prolonged time periods. This data, therefore, provides an opportunity to examine 
and redefine the allocation of these fruits and vegetables in the diet. 
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Chapter 5 
24 hour plasma phenylalanine 
variability in PKU 
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5.1 Introduction 
There are no data on 24-hour variability of phenylalanine concentrations in children with 
PKU. Consequently, it is not known what extent a single phenylalanine concentration taken 
at the same time each day is representative of an entire 24-hour period. 
In Chapter 2, large within-patient variations in phenylalanine concentrations were found 
according to the timing of ingestion and distribution of protein substitute throughout the day. 
However, that study was limited, in that phenylalanine concentrations were measured at only 
two set time points within each 24-hour period. The methodology used may therefore have 
failed to detect considerable and therapeutically important inter- and intra-individual 
variation in phenylalanine concentrations throughout the remainder of the 24-hour period. 
The purpose of this study was to investigate in detail the circadian rhythm of plasma 
phenylalanine in well-controlled children with PKU. The aims were to identify a) the 
highest and lowest phenylalanine concentrations within a 24-hour period; b) to determine 
the length of time for which plasma phenylalanine concentrations are outside the 
recommended MRC Working Group (MRC, 1993b) range; and c) to investigate the extent a 
single value was representative of an entire 24-hour period. It is possible that extra 24-hour 
phenylalanine data may alter clinical decisions on dietary management. 
5.2 Subjects and methods 
5.2.1 Subjects 
Sixteen patients (fifteen Caucasian and one Afro-Caribbean) with classical PKU were 
recruited. There were three inclusion criteria; 1) maintenance of plasma phenylalanine 
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concentrations (weekly, fortnightly or monthly according to age group) within the ranges 
recommended by the MRC Working Group (MRC, 1993b) for 70% of the six months before 
entering the study; 2) over 1 year of age; and 3) parental ability to take skin puncture blood 
specimens at home by thumb prick. There were 12 girls and 4 boys, with a median age of 
six years (range 1 to 18 years). 
The median number of 50 mg phenylalanine exchanges allocated was six per day (range 3.5 
to 18) with an equivalent median natural protein intake of 6g daily. The following amounts 
of total protein/kg/day from protein substitute and phenylalanine exchanges were allocated:- 
children 1 year of age: 3.0g/kg; 2-5 years: 2.5gkg; 6-10 years: 2.0g/kg; over 11 years of 
age: 1.5g/kg. The brand of protein substitute used was chosen by the patient and was 
administered either as a paste or drink. Nine patients used XP Maxamaid (Scientific 
Hospital Supplies), six used Phlexy 10 Drink Mix (Scientific Hospital Supplies) and one 
used Aminogran Food Supplement (UCB Pharma). 
The study was approved by the Committee on Medical Ethics of South Birmingham Health 
Authority. Informed consent was obtained from all parents and from all competent patients. 
5.2.2 Methods 
Assessment of plasma phenylalanine concentrations 
Patients attended the Children’s Hospital for 13 hours during one day. Following application 
of topical anaesthetic cream, indwelling venous cannulae were inserted and kept open 
throughout the study period by intermittent insertion of heparinised saline. Blood samples 
for phenylalanine estimation were collected into heparinised tubes at hourly intervals from 
120 
09.00h to 21.00h inclusive. The study was continued at home through the remainder of the 
24-hour period, with parents taking heel or thumb serial skin puncture blood specimens at 
midnight, 03.00h and 06.00h. Blood collection technique had been taught and competence 
assessed by a specialist nurse. The night-time blood specimens were then collected within 
four hours of study completion and taken to the laboratory the same day. All the blood 
specimens were centrifuged upon receipt and resulting plasma samples stored at -20°C until 
analysed. Plasma phenylalanine concentrations were measured by HPLC as previously 
described. 
The child’s usual daily activity was maintained as closely as possible during the day of the 
study. Children under 10 years took part in school type activities in the morning, were 
entertained by a clown in the afternoon, and watched videos and television in the evening. 
Older patients watched videos, listened to music and read magazines throughout the day. 
Children were free of intercurrent infections on the day of study. 
Assessment of phenylalanine, protein substitute and energy intake 
Customary food intake was maintained as closely as possible on the day of study. Patients 
ate their usual breakfast at home prior to their first blood test. Packed lunches were 
provided, and later, an evening meal similar to what they would have at home was eaten. All 
food and drink intake was documented during the study, including any taken prior to the first 
blood test of the study. Food to be eaten was weighed using Salter electronic scales 
(accurate to 5g), about which parents or older subjects had been instructed. Parents recorded 
only food and drink actually consumed; remaining food was re-weighed and deducted from 
the total start weight. The weighing and recording of food and drink during the day was 
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supervised. Timing and quantity of protein substitute consumed was also recorded 
prospectively. 
Nutritional analysis of food intake was calculated using the Microdiet computer programme 
based on McCance & Widdowson’s “The Composition of Foods” (Holland et al, 1991), with 
supplementary analysis data provided by manufacturers and added to the database as 
described in chapter 2. Energy intake was calculated as a percentage of the EAR (DH, 
1991). 
5.3 Statistical analyses 
Statistical analysis was by Pearson Product Moment Correlation coefficient (Y) comparing 
change in phenylalanine concentrations with timing of protein substitute intake; One-way 
Analysis of Variance and Tukey-Kramer Multiple Comparisons Test to compare nutrient 
intake between meal times. 
5.4 Results 
5.4.1 Plasma phenylalanine concentrations 
There was a wide variation in plasma phenylalanine concentration over the time period 
studied (Fig 5.1 , 5.2 and 5.3). The median (range) variations in plasma phenylalanine 
concentrations were as follows: 
1-5 year olds 150(110-220) n = 5  
6-1 O year olds 180(100-280) n = 4  
11-18 year olds 170(80-220) n = 7  
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There was no correlation between age and change in plasma phenylalanine concentrations. 
The highest phenylalanine concentration in most children occurred in the morning and 63% 
attained their highest level between 06.00h and 09.00h (Fig 5.4). However, in 31% the 
highest concentration did not occur until after midday and in 19% the peak occurred in late 
afternoon. In contrast, almost all patients had their lowest phenylalanine concentrations after 
midday, 63% reaching their lowest point between 18.00 hours and midnight (Fig 5.4). 
The first plasma phenylalanine concentration at 09.00h did not reflect the overall pattern of 
control for the entire 24-hours studied in 44% (n = 7) of the subjects. In 25% (n = 4) of 
subjects plasma phenylalanine concentrations were within recommended guidelines at 
9.00 h, but mean concentration were below 100 for the rest of the 24-hours. In 19% 
(n = 3) of the subjects, 9.00 h plasma phenylalanine concentrations were higher than 
recommended guidelines but mean concentrations were within or almost within 
recommended guidelines for the overall time period. The 24-hour mean phenylalanine 
concentration (292 SD 226) was significantly less than the mean first blood 
phenylalanine concentration taken at 9.00 h (338 SD 195) (p <0.001). Only in two 
subjects were the 9.00h plasma phenylalanine concentrations lower than the 24-hour mean. 
Individual early morning and mean phenylalanine concentrations are outlined in Table 5.1 
and Fig 5.5. 
Phenylalanine concentrations of less than 100 occurred in 46% of children aged 10 
years or below (n = 5/11). The length of time the phenylalanine concentration remained 
below 100 varied from 50-77% of the 24-hour period studied. Three children had 
concentrations of less than 30 for 2,6 and 7 hours, but in each of these phenylalanine 
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Table 5.1 
First early morning plasma phenylalanine concentration compared 
with mean 24-hour plasma phenylalanine concentrations 
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concentrations were over 100 at 9.00 a.m. in the morning. In these children, the 
median phenylalanine for the day was 65 Only one child of 10 years or under had 
phenylalanine concentrations above the MRC range guidelines (MRC, 1993b) (for 27% of 
the time period studied), but 3 of 5 subjects over 11 years had phenylalanine concentrations 
above the MRC guidelines for 24% of the time period studied. Daily changes in plasma 
phenylalanine concentrations are given in Table 5.2. 
5.4.2 Dietary intake 
Neither the energy or total protein intake correlated with the change between highest and 
lowest plasma phenylalanine concentrations in 24 hours (Fig 5.6 and 5.7). The median 
(range) energy intake was 117% (60-208%) of the EAR (DH, 1991). More energy was 
consumed at lunch and evening than breakfast (breakfast vs lunch p <0.01 ; breakfast vs. 
evening p <0.01) (Fig 5.8). Equally more carbohydrate was consumed in the evening than 
breakfast (p <0.05) (Fig 5.9), and more fat was consumed at lunch and evening than 
breakfast (p <0.05) (Fig 5.10). 
The median (range) total protein intake was 230% (151-321%) of the RNI (DH 1991). The 
subjects consumed a median (range) excess of 36% (-15-183%) natural protein from free 
foods in addition to their phenylalanine exchanges. There was no correlation with excess 
protein intake and change between highest and lowest blood phenylalanine concentrations 
(Fig 5.11). The majority of the natural protein was eaten in the evening with just over a 
quarter being eaten at breakfast and lunch (breakfast vs. evening p<0.01 ; lunch vs. evening 
p <0.05) (Fig 5.12). Thirty one percent (n = 5/16) of subjects ate more than 50% of their 
natural protein intake in the evening. However, this had no significant effect on blood 
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Table 5.2 
Age, phenylalanine exchanges, daily changes in plasma 
phenylalanine concentrations. 
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phenylalanine concentrations within 1 to 2 hours of mealtime consumption. The 24-hour 
blood phenylalanine profile of each of these 5 patients is given in Fig 5.13. 
The timing of protein substitute intake was the only factor that affected change in plasma 
phenylalanine concentrations. The greater the quantity of protein substitute consumed by the 
16.00h specimen, the larger the decrease in daytime phenylalanine concentration 
(r = -0.5711) (p <0.05) (Fig 5.14). The less protein substitute consumed after 16.00h, the 
larger was the increase in plasma phenylalanine concentration between 16.00h to 06.00h the 
following morning (r = 0.65 16) (p = 0.0062) (Fig 5.15). Sixty three percent (n = 1 O) of the 
subjects took the protein substitute in 3 doses, split between morning, lunch/afternoon and 
evening; 25% (n = 4) took the protein substitute in 2 doses; and 12% (n = 2) took the protein 
substitute in 4 doses throughout the waking hours. Slightly more protein substitute was 
taken at breakfast than at lunch and evening meal, but the difference was not significant (Fig 
5.16). 
5.5 Summary 
In conclusion, there is wide variability in phenylalanine concentrations throughout the day in 
children with PKU. A single early morning blood phenylalanine concentration does not 
predict quality of phenylalanine control in PKU and in 44% of subjects it gave misleading 
information about overall 24-hour phenylalanine control. In this study the median difference 
between highest and lowest concentrations observed was 155 with peak 
concentrations usually occurring before midday, and lowest in the afternoon or evening. 
Although only 16 patients were studied in a single 24-hour period they represented a wide 
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age range and all had classical PKU. The main dietary factor that appeared to be responsible 
for the variable phenylalanine concentrations was the uneven distribution of protein 
substitute during daytime hours. Adjusting the timing of protein substitute intake may lead 
to more stable 24-hour plasma phenylalanine profiles in PKU and ensure early morning 
plasma phenylalanine concentrations give a more accurate picture of overall phenylalanine 
control. 
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Chapter 6 
Part A 
The effects of altered timing of administration 
of protein substitute on variability in plasma 
phenylalanine concentrations 
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6.1 Introduction 
Plasma phenylalanine concentrations vary widely in children and adolescents with PKU. In 
Chapter 5 ,  in the study on 24-hour plasma phenylalanine variability in PKU, the median 
variation within 24 hours was 155 with peak concentrations usually occurring before 
midday; lowest concentrations tending to occur in the afternoon or evening. The reasons for 
this were unclear, but there was some evidence to suggest it was probably due to the uneven 
distribution of the L-amino acid phenylalanine-free protein substitute. 
In this study, the hypothesis that administration of protein substitute over longer daytime 
hours in more frequent and smaller doses leads to improved control compared with the 
conventional practice of three doses taken with main meals, was examined. Children with 
well-controlled PKU (according to current MRC 1993b criteria*) were entered into a 
randomised, crossover study in which three protocols of protein substitute administration 
were compared. 
6.2 Subjects and methods 
6.2.1 Subjects 
Fifteen patients (14 Caucasian and 1 Afio-Caribbean) with classical PKU were recruited. 
There were three inclusion criteria: 1) maintenance of at least 70% plasma phenylalanine 
concentrations (weekly, fortnightly or monthly according to age group) within ranges 
* Children 0-5 years maintained blood phenylalanine concentrations between 120-360 
school age children 120-480 children >10years 120-700 
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recommended by the MRC Working Group (MRC, 1993) in the six months before entering 
the study; 2) over 1 year of age; and 3) demonstrable parental ability to take heel and thumb 
prick blood specimens at home. Twelve girls and three boys, with a median age of 4 years 
(range 1 to 20 years) fulfilled these criteria and agreed to enter the study. 
The median number of 50 mg phenylalanine exchanges allocated was six per day 
(range 3.5-16) with an equivalent median natural protein intake of 6g daily. The following 
amounts of total protein from protein substitute and phenylalanine exchanges were 
allocated:- age <2 years: 3.0g/kg/day; 2-5 years: 2.5g/kg/day; 6-10 years: 2.0g/kg/day; 
over 11 years of age: 1.5g/kg/day. 
Patients continued to take their usual brand of protein substitute throughout the study. This 
was taken either as a paste or a drink. Ten patients used XP Maxamaid (Scientific Hospital 
Supplies); four used Phlexy 10 Drink Mix (Scientific Hospital Supplies); and one used PK 
Aid 4 (Scientific Hospital Supplies). XP Maxamaid and Phlexy 10 Drink Mix are based on 
L-amino acids and supplemented with carbohydrate; PK Aid 4 is based on L-amino acids 
only. 
The study was approved by the Committee on Medical Ethics of South Birmingham Health 
Authority. Informed consent was obtained from all parents and all competent patients. 
6.2.2 Study design (Fig 6.1) 
This was a multiple, randomised, crossover study that was conducted at home. Each patient 
took the protein substitute for a period of 7 days as follows (Figure 6.1): 
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Fig 6.1 Study design: Percentage dosage and 
time of administering protein substitute 
(Protocol A, Protocol B, Protocol C) 
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Protocol A : one third of the protein substitute administered in three doses over a 1 O hour 
period, with doses taken between 7.00-8.00 h, 12.00-13.00hY and 17.00-18.00h. 
Protocol B: one third of the protein substitute administered in three doses over a 14 hour 
period, with a dose between 7.00-8.00hY 15.00-16.00h and 21.00-22.00h. 
Protocol C: one quarter of the protein substitute administered in four doses over a 14-hour 
period, with a dose between 7.00-8.00hY 12.00-13.00hY 17.00-18.00h and 21.00-22.00h. 
There was no washout time in between the protocols. The randomisation order was 
generated in blocks of four. Each subject’s randomisation order was retained in a sealed 
envelope until after the subjects or carers had signed the consent form. 
Assessment of plasma phenylalanine concentrations 
Subjects or their parents took 4 hourly heel, finger or thumb skin puncture blood specimens 
on day 6 and day 7 of each study period at the following times: 4.00 h, 8.00h, 12.00h, 
1 6.00h, 20.00h and 24.00h. Plasma specimens were repeated for 2 days to test 
reproducibility at different time points. Blood collection technique had been taught and 
competence assessed by a specialist nurse. After each study period, blood specimens were 
collected from home and taken to the laboratory within 8 hours of collection of the final 
specimen. All blood specimens were centrifuged immediately upon receipt and the resulting 
plasma samples stored at -20°C until analysed. Plasma phenylalanine concentrations were 
measured using HPLC as described previously. Subjects maintained their usual activities 
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throughout the study. All children were free of intercurrent infections at the time of the 
study. 
Assessment of phenylalanine, protein substitute and energy intake 
All subjects were requested to take at least one half to one phenylalanine exchange with each 
dose of protein substitute. No more than 50% of the natural protein allowance was taken at 
any one meal, although the number of mealtime phenylalanine exchanges could vary during 
the study provided the daily allowance was not exceeded. 
All food and drink was recorded during day 6 and 7 of each study period to i) monitor 
adherence with and timing of phenylalanine exchanges and ii) calculate energy, carbohydrate 
and fat intake (there is evidence to suggest that carbohydrate may enhance protein utilisation 
and fat may slow the rate of amino acid absorption). Food was weighed using Salter scales 
(accurate to 5g) about which parents or older subjects had been instructed. Parents recorded 
only food and drink actually consumed; any remaining food was reweighed and deducted 
from the start weight. Timing and quantity of protein substitute consumed was recorded 
prospectively throughout the trial. 
Nutritional analysis of food intake was calculated using the Microdiet computer programme 
based on McCance & Widdowsons’s ‘The Composition of Foods ’ (Holland et al, 1991) with 
supplementary analysis data provided by manufacturers and added to the data base as 
described in chapter 2. Energy intake was calculated as a percentage of the estimated 
average requirement for energy (DH, 1991). 
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6.3 Statistical analyses 
One-way analysis of variance was used compare differences between the 3 trial periods. 
Pearson’s Product Moment Coefficient (Y) was used to compare change in phenylalanine 
concentrations with timing of protein substitute intake. Multivariate analysis of variance 
was used to compare plasma phenylalanine results at all time points simultaneously between 
protocols. A general linear multivariate analysis of variance was used to compare changes in 
plasma phenylalanine concentrations between different time intervals and a Chi-square test 
to compare differences between the highest and lowest concentrations in the 3 protocols. 
6.4 Results 
6.4.1 Subjects withdrawn from the study 
Fourteen subjects (1 1 girls; 3 boys) completed the study. One 2 year old girl was withdrawn 
because she refused blood tests at night. 
6.4.2 Effect of administration of protein substitute protocol on 24 h 
plasma phenylalanine pattern 
Each of the three different study protocols of protein substitute administration produced a 
different 24-hour phenylalanine curve or pattern (Fig 6.2 Protocol A; Fig 6.3 Protocol B; 
Fig 6.4 Protocol C). Figure 6.5 demonstrates that when comparing simultaneously the 
means of all plasma phenylalanine concentrations from all time points in each protocol, the 
24-hour profile for each was significantly different (A v B; A v C; B v C p <0.0001) 
(Table 6.1). 
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Table 6.1 
Multivariate analysis of variance comparing the means of all 
plasma phenylalanine concentrations from all time points 
simultaneously of the three different protocols 
Table 6.2 
Mean change in plasma phenylalanine concentrations between 
blood sampling times at 4h intervals in each study protocol 
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Table 6.2 demonstrates when comparing the changes in plasma phenylalanine concentrations 
at 4 hourly intervals between the three protocols using a general linear model of analysis of 
variance there was a significant difference between protocols for all time points except 
between 8.00 and 12.00 h. 
6.4.3 Change between highest and lowest phenylalanine 
concentrations observed 
Figure 6.6 shows a wide difference between highest and lowest phenylalanine concentrations 
observed in 24 hours for all three study protocols. The mean (SD) change in plasma 
phenylalanine concentrations were as follows: 
Protocol A: 136 (38) 
Protocol B: 110 (32) 
Protocol C: 129 (42) 
Protocol B produced significantly less change than the other two protocols. In protocol B, 
79% of phenylalanine concentrations changed by 120 or less within all the 24 hour 
time periods studied compared with 35% in protocol A; and 48% in protocol C (p <0.005) 
(Fig 6.6). 
6.4.4 Effect of time since giving dose of protein substitute and 
change in plasma phenylalanine concentrations 
When examining the interval since giving the last dose of protein substitute and change in 
plasma phenylalanine concentration there appears to be a similar pattern in all 3 protocols 
(Figs 6.7 - 6.12). When examining all and mean changes in plasma phenylalanine 
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concentrations in all 3 protocols, there was an initial depression in phenylalanine 
concentration reaching a peak at 4 hours. This was then followed by a rapid increase in 
concentrations, which reached a plateau after a further 3 - 4 hours. 
6.4.5 Phenylalanine concentrations outside the MRC (I993b) 
recommended guidelines 
Figure 6.13 shows that all three methods of administering protein substitute resulted in more 
than a quarter of all phenylalanine concentrations being lower than the MRC recommended 
guidelines (MRC, 1993b), despite 08.00h concentrations being within the target range. In 
protocol A, 29% of all phenylalanine concentrations were below 100 3 1 % in 
protocol B and 26% in protocol C. There were no significant differences between the three 
groups. 
Only 5% of phenylalanine concentrations exceeded the MRC upper limit of 700 in 
protocol C (MRC, 1993b). This was in 2 older subjects who both had a 08.00h 
concentration just above the accepted range. 
6.4.6 Within subject reproducibility of plasma phenylalanine 
concentrations on day 6 and day 7 of each study protocol 
There was good within subject reproducibility for the majority of the subjects between 
phenylalanine concentrations taken at the same times on the consecutive days of each 
protocol. For 90% of the individuals the correlation coefficient (r)  was >0.6 for the three 
study protocols. 
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6.4.7 Protein and energy intake 
There was no significant difference in overall energy intake between the three protocols. 
The mean daily energy intake as a percentage of EAR (DH, 1991) for protocols A, B and C 
was 94% (SD 27%), 96% (SD 19%) and 97% (SD 20%) respectively. Energy intake was 
also calculated every four hours to coincide with the blood sampling times. Overall, there 
was no difference in energy intake before 16.00h between the three protocols, but there was 
less energy consumed between 16.00 to 20.00h in protocol B (p <0.01) when no protein 
substitute was administered and more after 20.00h when 33% of protein substitute was taken 
(p <0.05). This was due exclusively to the carbohydrate added to the protein substitute and 
energy supplied by amino acids (Table 6.3). 
The total protein intake was similar in the three protocols (mean % protein intake of the 
RNI: protocol A: 253% (SD 53%); B: 261% (SD 55%); and C: 262% (SD 54%)). There was 
also no significant difference in natural protein intake between the three protocols or within 
the same four-hour time periods for which blood specimens were taken (Table 6.4). 
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6.5 Summary 
This study demonstrates that manipulation of the timing and dosage of protein substitute in 
PKU changes the plasma phenylalanine pattern over 24-hours. However, administration of 
protein substitute over extended daytime hours and in smaller doses does not lead to 
improved control of phenylalanine concentrations. With all 3 methods of administering 
protein substitute, the difference between the highest and lowest concentrations still 
exceeded 100 However, this study does show that administration of 25 - 33% of the 
daily protein substitute allowance at any one time causes a decrease in phenylalanine 
concentrations. This change seems to persist for approximately four hours. If protein 
substitute was not given for more than 4 hours, plasma phenylalanine concentrations rose 
quickly. Therefore, adjusting the timing of protein substitute during daytime hours does not 
improve 24-hour plasma phenylalanine profile. 
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Chapter 6 
Part B 
The effects of frequent administration of 
protein substitute on plasma phenylalanine 
concentrations 
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6.6 Introduction 
In chapter 6A, it was demonstrated that protein substitute in three to four daytime doses 
caused non-physiological variability in plasma phenylalanine concentrations in PKU. 
Giving protein substitute depressed phenylalanine concentrations and there is some evidence 
to suggest that the effect is related to the quantity and timing of protein substitute intake. 
It was hypothesised that plasma phenylalanine variability will be significantly reduced by 
giving protein substitute in small equal doses, every four hours both day and night. 
Therefore, in a small, randomised, cross-over study, the effect of administering protein 
substitute every four hours day and night on plasma phenylalanine was compared with two 
different protocols of giving protein substitute in three equal doses during the day. 
6.7 Subjects and methods 
6.7.1 Subjects 
Three patients (all Caucasian) with well-controlled classical PKU were recruited. The 
inclusion criteria were the same as described in the previous study. Two girls and one boy, 
aged 7, 8 and 11 years fulfilled these criteria and agreed to enter the study. Five, 6 and 7.5 
fifty-milligram phenylalanine exchanges were allocated to each child respectively. The two 
children under 10 years took 2.0g/kg/day of protein substitute, and the patient over 11 years 
1.5g/kg/day. They used their usual brand of protein substitute. The two girls took XP 
Maxamaid (Scientific Hospital Supplies), supplemented with Aminogran Food Supplement 
(UCB Pharma) and the boy took Phlexy 10 Drink Mix (Scientific Hospital Supplies) to 
achieve target protein requirements. 
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Fig 6.14 Study design: Percentage dosage and 
time of administering protein substitute 
(Protocol A, Protocol B, Protocol C) 
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6.7.2 Study design 
The study design was similar to the previous protein substitute timing study, with the protein 
substitute administered in 3 different ways over separate protocols to each subject. Protocol 
A and B were exactly the same as before. However, in protocol C, patients took their 
protein substitute in 6 equal doses at 8.00h, 12.00h, 16.00h, 20,00h, 24.00h and 4.00h for 
3 consecutive days only (Fig 6.14). Parents took 4 hourly finger or thumb skin puncture 
blood specimens on the last 2 days of each study protocol at the following times: 4.00h, 
8.00h, 12.00h, 16.00h, 20.00h and 24.00h. They were analysed as before. 
The patients were requested not to take a phenylalanine exchange with every dose of protein 
substitute in protocol C, due to the impracticalities of expecting children to eat as well as 
take protein substitute during the night. However, it was requested phenylalanine exchanges 
were taken with all protein substitute doses in protocol A and B. 
All food and drink consumed was recorded as before on the last 2 days of each protocol. 
6.8 Statistical analyses 
No statistical analyses were performed as only 3 subjects were studied. 
6.9 Results 
6.9.1 Effect of administration of protein substitute protocol on 24h 
plasma phenylalanine pattern 
Each of the three different study protocols of protein substitute administration produced a 
different 24-hour phenylalanine curve or pattern. The pattern for protocol A (Fig 6.15) and 
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protocol B (Fig 6.16) was similar to the ones observed in the previous study (chapter 6A). 
However, the pattern observed in protocol C (Fig 6.17) was very different. There was little 
change in plasma phenylalanine concentrations between different time points, and almost a 
straight line was produced over 24 hours. The majority of phenylalanine concentrations 
were below 100 
The mean (range) of plasma phenylalanine concentrations for all subjects at 4 hourly 
intervals, from the three different protocols, is given in Table 6.5. 
Table 6.5 
Mean plasma phenylalanine concentrations for 4 hourly intervals 
for three different protocols of administering protein substitute 
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6.9.2 Change between highest and lowest phenylalanine 
concentrations observed 
Figure 6.1 8 indicates the change between highest and lowest observations was much lower 
for protocol C, than protocol A and C .  
The mean (SD) difference in plasma phenylalanine concentrations were as follows: 
Protocol A: 160 (100 - 240) 
Protocol B: 90 (50 - 170) 
Protocol C: 43 (20 - 80) 
Mean change in blood phenylalanine concentrations between 4 hourly blood specimens did 
not exceed -23 (range 18 to -23 in protocol C compared with a maximum 
mean change of -60 (range -60 to 55 in protocol B and 115 (range 
-65 to 115 in protocol A. 
6.9.3 Energy and protein intake 
The mean energy intake compared with the EAR (DH 1991) was 103% (range 66-13 1%) in 
protocol A, 92% (range 78-1 15%) in protocol B, and 109% (81-126%) in protocol C 
(Table 6.6). A small quantity of energy supplied by the amino acids and carbohydrate added 
to the protein substitute was taken throughout the night in protocol C ,  but was much less 
than the energy consumed during the day. The total protein intake (from protein substitute 
and natural protein) was much higher than RNI (DH, 1991) in all three protocols 
(protocol A: mean 246% (range 167-300%); protocol B: mean 212% (range 161-252%); 
protocol C: mean 236% (range 170-304%). There was a large discrepancy between the 
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allocated phenylalanine (protein) exchanges and actual natural protein intake. Although the 
mean allocated phenylalanine exchanges (assuming 50 mg phenylalanine is equivalent to 
1 g natural protein) was 6.2 daily, the mean natural protein consumed in protocol A was 
1 1.4g (range 10-1 3g) daily. In protocol B, it was 9.7g (range 7.7-12.4g) daily and, in 
protocol C, it was 12.1g (range 8.4-15g) daily. Natural protein was not taken with every 
dose of protein substitute; and it was not equally distributed with meals. Indeed, over 50% 
of the daily natural protein were consumed in four out of nine meals in both protocols B and 
C (Table 6.7). However, this did not appear to adversely affect blood phenylalanine 
concentrations. 
6.10 Summary 
The repeated administration of protein substitute every four hours during the day and night 
leads to marked stabilisation of plasma phenylalanine concentrations in PKU. In fact, it 
produced a profile similar to the physiological pattern seen in non-PKU humans. It reduced 
mean daily variability between highest and lowest phenylalanine concentrations to less than 
50 In the few patients studied, it suppressed all phenylalanine concentrations, and 
they ran just below the lower MRC recommended limit for PKU (MRC, 1993b). However, 
concentrations remained stable and no concentrations fell below the lower normal accepted 
range for phenylalanine. Therefore, continual administration of protein substitute appears to 
be an effective tool in reducing phenylalanine variability in PKU. 
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Chapter 7 
Abnormal feeding behaviours 
in phenylketonuria 
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7.1 Introduction 
The low phenylalanine diet used in the treatment of PKU is one of the most restrictive and 
difficult of all diet therapies (Table 7.1). Given the central role that feeding and eating play 
in the life of a developing child, it is possible that such rigid dietary therapy may adversely 
affect feeding behaviour as well as nutritional status. 
Table 7.1 
Problems associated with a low phenylalanine diet 
Factor 
Variety: 
Natural foods: 
Protein subs ti tu te: 
Low protein special 
foods: 
Phenylalanine 
exchanges: 
Parent/carers: 
Problem 
Limited 
Very restricted 
Strong, bitter taste 
Dry, hard and bland 
Strict apportioning 
system 
Have to ensure all 
protein substitute and 
phenylalanine 
exchanges are taken 
The effect of such limited diet therapy has not been studied in PKU. Therefore, the feeding 
behaviour of young children with PKU was investigated to identify feeding patterns and to 
determine the type and incidence of feeding problems. 
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7.2 Subjects and methods 
7.2.1 Subjects 
All children aged 1 to 5 years (mean 3.0 years) attending the PKU clinic were studied. There 
were 12 girls and 3 boys. Each child was compared with an unrelated, age- and sex-matched 
non-PKU control child. Controls were selected by each mother of the PKU children 
identifying a friend of the same age and sex, living in similar housing and the same location. 
None of the control children were known to have any medical problems and none were or 
had been subject to any dietary restrictions. 
All the PKU children were on a strict low phenylalanine diet as described in Chapter 2. The 
median number of 50 mg phenylalanine exchanges allocated was 4 (range 3-7); total weight- 
related protein intake from both protein substitute and phenylalanine exchanges was 
3.0g/kg/day for children 1 year of age, and 2.5g/kg/day for children 2-5 years of age. 
Thirteen children, according to their preference, took a protein substitute of L-amino acids 
which incorporated carbohydrates, vitamins and minerals (i.e. X P  Maxamaid; Scientific 
Hospital Supplies); two preferred an L-amino acid supplement (i.e. Aminogran Food 
Supplement; UCB Pharma), with supplementary vitamins and minerals. 
The study was approved by the Committee on Medical Ethics of South Birmingham Health 
Authority. Informed consent was obtained from all parents. 
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7.2.2 Methods 
Assessment of feeding problems 
Feeding assessment questionnaire 
The mothers of all the children completed a feeding assessment questionnaire (Harris and 
Booth, 1992) administered by one researcher (Appendix 7.1). The questionnaire examined 
maternal perceptions of the incidence and type of feeding problems, considering appetite, 
gastrointestinal symptoms and feeding environment as well as feeding behaviour, feeding 
patterns, feeding skills, parental management and food preferences. A subjective five point 
positive-negative rating scale was used to determine parental feelings about children’s 
mealtimes and appetite. A supplementary questionnaire was administered to mothers of 
PKU children to examine their perception of ease or difficulty of protein substitute 
administration (Appendix 7.2). 
Video-recorded meals 
A video recording of each child eating a midday meal at home was made by the same 
researcher (AM). This did not include the administration of the protein substitute. All 
communication between the carer(s) and child was recorded. The video camera was in open 
view, but carers were asked to continue their normal mealtime activity. The investigator 
visited each house one hour prior to recording so the children could become used to her 
presence. The video-recorded meals were analysed using a scored category system based on 
the observed behaviour of both mother and child during the mealtime. (Thomas and Harris, 
1993) (Appendix 7.3). The analysis comprised the number of times the child became 
distracted from the meal, the manner in which the child’s attention was redirected back to the 
meal, the number of mouthfuls eaten during the meal, child and parental vocalisations; and 
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parental intervention during the mealtime. Child behaviour during mealtime and meal 
duration to the nearest minute was also documented. 
The video analyses were carried out by one observer. In order to verify reliability of the 
“observer” scoring technique, analysis of a five minute “snapshot” of 10 of the videos (five 
with PKU and five control) was carried out by a second investigator blinded to the PKU 
control status of each subject. There was a high degree of correlation for individual fifteen 
variables checked, with a minimum correlation coefficient of r = 0.8232 and a maximum of 
r = 0.9756. 
Dietary intake 
Mothers recorded 3-day food intakes using household measurements such as tablespoons and 
teaspoons to describe portion sizes from Sunday to Tuesday inclusive. Mothers recorded 
only food actually eaten, cooking techniques and food brand. They returned nutritional 
labels of manufactured foods eaten. Nutritional analysis of food intake was calculated as 
described in Chapter 2. 
Anthropometry 
Anthropometric data were collected at the time of the video recording. Weight to the nearest 
10g, was measured using portable electronic scales. Length was recorded to the nearest 
1mm by measuring supine length by an infantometer in children less than 2 years, and 
standing height in children over 2 years using a Harpenden Stadiometer. Length/height 
measurements were then converted into z scores, which denotes units of standard deviation 
from the median. 
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7.3 Statistical analyses 
Statistical analysis was by unpaired t-tests, Mann-Whitney and Fisher's exact test to compare 
the differences between the PKU and control group. The Pearson Product Moment 
Correlation Coeficient was used to compare the difference between the observer and 
independent observer for video scoring. 
7.4 Results 
7.4.1 Feed i n g assessment questionnaire 
Children with PKU were perceived by mothers to have more feeding problems 
(Table 7.2). Gastrointestinal symptoms (constipation, diarrhoea, and/or abdominal pain) 
were more common in the PKU group (p <0.05) (Fig 7.1). However, mothers reported no 
differences in frequency of individual negative feeding behaviour such as gagging, pushing 
food away, or closing the mouth when offered food. Of 70 incidents of negative feeding 
behaviour reported, 41 were reported in the PKU group and 29 in the control group, but 
these differences were not significant. 
Sweet foods were less popular in the PKU children and were disliked by almost half of the 
children studied (Table 7.3). A 5-point subjective positive-negative rating (with a score' of 1 
being the highest) determining parental feelings and impressions about mealtime indicated 
that mothers of the PKU group felt their children were more difficult to feed. The PKU 
group scored a median of 3.0 (range 1-5); the control group a median of 1.0 (range 1-3); 
p <0.001. Using the same positive-negative rating scale, mothers of PKU children reported 
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that their children did not eat enough: PKU group median 3.0 (range 1-5); control group 
median 1.0 (range 1-4) (p <0.001). Despite these differences, mothers of PKU children did 
not indicate they found mealtimes specifically more stressful, tearful or hectic than the 
control group. 
7.4.2 Video analysis 
Meal duration 
The children in the PKU group were slower to feed. The median (range) meal duration for 
the PKU group was 24 minutes (5-73 minutes) and for the controls, 16.0 minutes (10-35 
minutes) (p <0.05). Sixty seven percent of the PKU group took over 20 minutes to eat their 
midday meal compared with 20% in the control group (p <0.05) (Fig 7.2). Sixty percent of 
the PKU group ate less than two mouthfuls per minute, but all of the children in the control 
group ate more than two mouthfuls per minute (p <0.001). 
Child feeding behaviour (Table 7.4) 
The children in the PKU group were less likely to start eating their meal without prompting 
(p <0.005). Although the PKU group were more easily distracted from the task of eating, 
turned their head away or closed their mouth when offered food and expressed more 
negative and less positive vocalisations about food, these differences were not significant. 
Parental management and strategies (Table 7.5) 
In both groups, most children ate at a table or high chair at mealtimes (PKU group 65%, 
control group 87%). However, the children in the PKU group were more likely to be given 
their midday meal separate from the rest of the family (PKU group 67%, 
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control group 20%; p <0.05) (Fig 7.3). For every 10 minutes of the mealtime, there was less 
parental feeding directed verbalisation e.g. asking if the food was nice, or good in the PKU 
group, than in the control group (p <0.01). There were more parental prompts reminding the 
children to eat but less parental praise in the PKU group (p <0.05) (Fig 7.4). 
Parental strategies more commonly employed in the PKU group to persuade children to eat 
included bribery, distractions and threats, but with the exception of bribes (p <0.05), the 
differences were not significant (Fig 7.5). Thirty three percent of mothers in the PKU group 
used more than three strategies to persuade their children to eat during the observed 
mealtime in the PKU group, compared with only 7% in the control group (p = 0.1686). 
7.4.3 Dietary assessments (Table 7.6) 
Although the mean energy intake, when compared to the estimated average requirement, 
(DH, 199 1) was higher in the control group than the PKU group, the difference was not 
statistically significant. In the PKU group, protein substitute contributed a mean 
intake of 34% (range 18-55%) of the energy. Children with PKU had fewer daily snacks; 
ate smaller portions and were generally offered fewer foods at mealtimes. A mean of 21 
different foods were consumed over 3 days in the PKU group compared with 36 in the 
control group (p <0.0001). 
7.4.4 Protein substitute administration 
Forty eight percent of the mothers of the PKU group said they had difficulty in persuading 
their children to take the protein substitute and only 38% said their children completed all of 
it every day. Sixty two percent of mothers supervised the protein substitute administration 
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and 19% said it took their children over one hour each day to complete, with one child taking 
as long as seven hours per day. Ninety one percent of the children took the protein substitute 
as a drink and 9% as a paste. Of the children taking it as a drink, as many as 48% still took it 
from an infant feeding bottle or beaker with teat attached as their parents could not persuade 
them to take it from an open cup or beaker. None of the children had their protein substitute 
administered via a gastrostomy or nasogastric tube. 
7.4.5 Anthropometry 
The PKU group of children had significantly lower weight z scores than the control group 
(p <0.05), but there were no significant differences between the two groups for height 
z scores (Fig 7.6). Two children in the PKU group had a height z score below -2. There 
was a significant correlation between weight and energy intake in the control group (p <0.05) 
(Fig 7.7), but this did not quite reach statistical significance in the PKU group (p = 0.0895) 
(Fig 7.8). 
7.5 Summary 
This study is the first to define feeding problems in young children with PKU. Forty seven 
percent of the mothers perceived their children to have at least 3 feeding difficulties. 
Principal problems perceived and observed were slowness to feed; a poor appetite; a dislike 
of sweet foods; and a limited variety of foods consumed. Parents also perceived their 
children to have more gastro-intestinal symptoms. It was observed that carers of PKU 
children resorted to more mealtime coercive strategies to persuade their children to eat, used 
less verbal encouragement at mealtimes and were more likely to feed their children in 
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isolation. Particular difficulties were experienced with the administration of protein 
substitute. Although PKU children were lighter and smaller than control children, only two 
PKU children were stunted (height age less than 2 standard deviations of reference value). 
However, both of these children had at least one small parent, and neither had low energy 
intakes. This study has therefore identified a number of feeding problems in young PKU 
children, some of which may be precipitated by the administration of protein substitute. 
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Table 7.4 
PKU 
n = 1 5  
Child feeding behaviour during midday meal: results of 
video analysis 
Control 
n=15 
Number of children needing parental 
prompting at beginning of meal to start 
eating 
10 1 
Median (range) number of times child O (0-5) 
turns head away when proffered food per 
10 minutes 
Median (range) number of times child O (0-2.7) 
closes mouth when proffered food per 10 
minutes 
Median (range) number of times child is 
distracted from task of eating per 10 
minutes 
2.9 (0-6.7) 
Mean (range) number of positive 0.6 (0-3.6) 
vocalisations from child per 10 minutes 
Median (range) number of negative 
vocalisations from child per 10 minutes 1.0(0-6) 
O (0-3.3) 
O (0-1.3) 
2.1(0-6) 
0.8(0-10) 
0.7(0-5) 
p value 
0.005 
NS 
NS 
NS 
NS 
NS 
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Chapter 8 
Discussion 
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8.1 Principal findings 
This work reports a series of original studies principally investigating the effects of diet on a) 
variability in blood phenylalanine concentrations and b) feeding behaviour in young children 
with PKU. Many of the studies have produced unexpected results, but provide a greater 
understanding of the factors affecting blood phenylalanine and the dietary problems faced by 
parents and young children. The main findings are summarised as follows: 
There was wide 24-hour variability in plasma phenylalanine concentrations in PKU that 
was not reflected in single early morning phenylalanine observations. 
Twenty-four hour variability was more influenced by the timing and dosage of protein 
substitute than total energy or excess natural protein intake from ‘freely’ allowed foods. 
Manipulation of timing and dosage of protein substitute during daytime hours did not 
improve 24-hour plasma phenylalanine profile. However, repeated administration of 
protein substitute every four hours day and night markedly reduced phenylalanine 
variability and produced stable and lower phenylalanine concentrations. 
Fruits and vegetables containing phenylalanine between 51-100 mg/100g did not 
adversely affect control and so can be incorporated ‘freely’ into the diet. 
New phenylalanine analysis for potatoes allowed a substantial increase in portion size, 
and prolonged testing indicated this did not adversely affect phenylalanine 
concentrations. 
A number of feeding problems was identified in young PKU children, some of which 
may be precipitated by administration of protein substitute. 
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The discussion is divided into three parts: 
- Interpretation and implications of results. 
Strengths and weaknesses of individual studies. 
- Unanswered questions and future research. 
- 
8.2 Interpretation and implication of research results 
8.2.1 Variability in blood phenylalanine concentrations 
In this thesis, the two studies (Chapter 2 and 5) examining plasma phenylalanine variability 
are the first to provide detailed knowledge about the wide 24-hour variability of plasma 
phenylalanine concentrations in such large groups of subjects in PKU. They show that 
phenylalanine concentrations do not stay within narrow target ranges over 24 hours for many 
patients. They also demonstrate that single early morning specimens in any one 24-hour 
period give an incomplete and unrepresentative picture of phenylalanine control for many 
children. They add further knowledge to the early work conducted by Güttler who measured 
twice daily phenylalanine concentrations in two children (Güttler et al, 1969); but conflict 
with those of van Spronsen who found little fluctuation in plasma phenylalanine 
concentration over five hours in eight subjects (van Spronsen et al, 1993). 
In chapter 2, the study demonstrated large diurnal fluctuations of plasma phenylalanine 
concentrations in a group of well-controlled PKU children. It showed that blood samples 
before breakfast did not always reflect the highest plasma phenylalanine concentrations of 
the day. It also showed that almost half of all evening plasma phenylalanine concentrations 
were less than 100 in children who had taken 65% or more of their protein substitute 
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by the time of their evening meal, despite having morning blood phenylalanine 
concentrations within the MRC recommended range (MRC, 1993b). For the study group 
overall, there was significantly greater variability in evening plasma phenylalanine 
concentrations than for morning concentrations. 
This study was limited in that phenylalanine concentrations were measured at only two time 
points within each 24-hour period. It might therefore have failed to detect considerable and 
therapeutically important inter-individual variation in phenylalanine concentrations 
throughout a 24-hour period. These findings and shortcomings prompted the need for the 
24-hour blood phenylalanine study (Chapter 5). This study demonstrated wide fluctuations 
in plasma phenylalanine concentrations throughout a 24-hour period. The median difference 
between highest and lowest concentrations was 155 Peak concentrations occurred 
before midday in only 69% of cases, but the lowest almost always occurred in the afternoon 
or evening. There was no correlation with age, and median variation in phenylalanine 
concentrations was similar in young and older patients. These findings have recently been 
confirmed by Francois and Diels who demonstrated wide variability in blood phenylalanine 
concentrations in a group of 10 patients with PKU aged from 12-30 years (Francois and 
Diels, 1998). 
Hypophenylalaninaemia 
The 24-hour variability study identified the range of time during which phenylalanine 
concentrations lay outside the MRC guidelines in ‘well controlled’ children. It demonstrated 
that if an early morning phenylalanine concentration was just above the MRC lower limit, 
and therefore considered satisfactory, it could be less than 100 for a significant time 
215 
during the 24 hours. It was of particular concern that the study identified a small number of 
children who had phenylalanine concentrations less than 30 for up to seven hours 
within a 24-hour period. 
Although there is no evidence that hypophenylalaninaemia is detrimental to long term 
neurological outcome, or that transient hypophenylalaninaemia is detrimental to intelligence 
quotient, it is only within the last four years in the UK that phenylalanine concentrations 
have been maintained within such narrow and low limits. There is some concern that long 
term low plasma phenylalanine concentrations may affect IQ and growth. In data from the 
National Phenylketonuria Register, Smith and co-workers showed that IQ fell by four points 
for each five months during which measured phenylalanine concentrations were below 
120 (Smith et al, 1988). However, the analyses of outcome of these results may 
relate largely to morning rather than evening concentrations, although blood-sampling 
timing was not specifically reported. In addition, plasma phenylalanine was analysed 
primarily from bacterial inhibition assays or paper chromatography, which are not 
particularly accurate at low concentrations. Some studies from the early 1970’s reported 
poor growth linked to overzealous restriction of dietary phenylalanine and low plasma 
phenylalanine concentrations in the first few months of life (Hanley et al, 1970; Smith and 
Waisbren, 1971). Furthermore, there have been three studies from Europe reporting 
improved growth in infants and young children with PKU (Dhont et al, 1995; Schaefer et al, 
1994; Verkerk et al, 1994). In the Netherlands, it has been shown that height z scores in 
children with PKU at the age of 3 years were less than reference values. For boys, this 
reflected an average decrease of 30 mm in expected height (Verkerk et al, 1994). These 
authors’ hypothesised treatment regimens aiming at maintaining lower phenylalanine 
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concentrations may lead to adverse effects on growth. Even so, they found no direct 
correlation between the percentage of phenylalanine concentrations less than 120 and 
poor growth, although they did not appear to correlate the actual extent by which 
phenylalanine concentrations fell below 120 with growth. They also recognised that 
other periods of hypophenylalaninaemia may have remained unidentified. 
Hyperphenylalaninaemia 
Phenylalanine concentration only rose above MRC working group upper reference ranges in 
subjects who had relatively high starting point concentrations (MRC, 1993b). In the 24-hour 
phenylalanine variability study, with the exception of one subject, higher than MRC 
recommended concentrations only occurred in teenagers who aimed to maintain their 
phenylalanine concentrations between 100 and 700 Phenylalanine concentrations 
over 700 for a significant proportion of a 24-hour period may have consequences for 
neuropsychological performance. Short-term concentrations over 800 have been 
associated with prolonged performance times on neuropsychological tests of higher 
integrative function (Krause et al, 1985). A phenylalanine concentration over 600 on 
the day of neuropsychological testing has also been associated with a sustained attention 
deficit and difficulty with calculation tasks (de Sonnerville et al, 1990). 
The 24-hour plasma phenylalanine variability study clearly demonstrates that single-point, 
early morning, phenylalanine concentrations were misleading and provide an incomplete 
picture of phenylalanine control in PKU. If it is not possible to lessen 24-hour plasma 
phenylalanine variability by dietary manipulation; it may be necessary to consider annual 
217 
24-hour plasma phenylalanine profiles in children with PKU to estimate the extent of 
individual phenylalanine variability and help with interpretation of phenylalanine 
concentrations. 
8.2.2 Dietary factors affecting variability in blood phenylalanine 
concentrations 
Timing and dosage of protein substitute intake 
In this thesis, it has been clearly demonstrated that plasma phenylalanine variability was 
strongly influenced by the timing and dosage of protein substitute intake. Administration of 
25% or more of daily protein substitute caused a decline in phenylalanine concentrations. If 
further protein substitute was not consumed for several hours, there was an increase in 
plasma phenylalanine. In the study on factors affecting variability in plasma phenylalanine 
(chapter 2), subjects who had taken 65% or more of their protein by the time of their 
evening meal showed a fall in plasma phenylalanine concentrations during the day. In 
contrast, subjects who delayed most or all of their protein substitute until after their evening 
meal showed an increase in plasma phenylalanine concentration through the day. 
In the 24-hour variability plasma phenylalanine study (chapter 5), eighty two percent 
(n = 13) of all the children took the protein substitute three or more times daily, but only 
44% (n = 7) took it at the recommended three to four hour intervals with meals. In the latter 
group there appeared to be persistent depression of phenylalanine concentrations during the 
daytime and early evening, but increased concentrations overnight. Younger children in 
particular were more likely to take the protein substitute in this way. The other 38% of the 
subjects (n = 6) ,  mainly older patients, took a late evening dose of protein substitute. They 
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had relatively small changes in phenylalanine concentration overnight ( -60 to 
+30 
When timing and dosage of protein substitute was altered during the day, the plasma 
phenylalanine pattern changed, but there was no reduction in plasma phenylalanine 
variability. In contrast, administration of protein substitute in equally divided doses 
throughout 24-hours reduced plasma phenylalanine variability to a rate almost equivalent to 
that of the normal physiological position. In addition, administration of protein substitute 
every 4 hours appeared to suppress phenylalanine concentration to the extent that almost all 
were below 100 Although only three patients were studied, no phenylalanine 
concentration fell below the normal lower limit, which was different from the situation when 
protein substitute was administered in only 3 or 4 doses during daytime hours only. 
Continual administration of protein substitute day and night may therefore improve 
phenylalanine tolerance. However, this has not been specifically tested. If similar results 
were obtained in a larger group of patients, and phenylalanine concentrations were not to fall 
below lower limits of normal, it may be possible to reduce the lower range of blood 
phenylalanine concentrations permitted in PKU. 
Explanatory mechanisms for action of protein substitute on plasma 
phenylalanine concentrations 
It is likely that administration of protein substitute helps promote protein synthesis. The 
proteins of the body are continually being broken down and replaced. Tissue protein 
breakdown occurs at a more or less constant rate throughout the day. An adult catabolises 
and replaces about 3-6g of protein/kg/body weight per day (Bender, 1997). In the fed state 
when feeding normally, there is an abundant supply of metabolic fuel and the rate of protein 
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synthesis increases, exceeding that of breakdown. This causes a net increase in tissue 
protein, and replaces what is lost when in a fasting state. In the fasting state, this leads to a 
net loss of tissue protein by liberating amino acids, including phenylalanine, into the plasma 
pool, to supply a source of energy. In healthy individuals, these amino acids are largely 
oxidised. In people with PKU, however, phenylalanine cannot be hydroxylated, and so the 
plasma phenylalanine concentration increases. It is interesting to note that phenylalanine 
concentrations still increase during the day, even when no protein substitute is administered 
but a supply of dietary energy is maintained. Millward and Rivers give a model for the 
utilisation and influence of dietary amino acids (Millward and Rivers, 1988). 
It is possible that administration of protein substitute in a single daily dose, particularly when 
given in the form of L-amino acids, led to the extremes in variability of plasma 
phenylalanine concentrations seen in Chapter 5. L-amino acids are absorbed rapidly. In a 
study on ten normal men, administration of a single dose of L-amino acid resulted in an 
initial rise in plasma amino acids. However, after 90 minutes, there was a rapid decline in 
phenylalanine and, by 240 minutes, the concentrations had fallen below the baseline figure 
(Gropper, Gropper and Acosta, 1993; Gropper and Acosta, 1991). In addition, there is 
evidence that amino acids given in single doses lead to increased oxidative utilisation 
(Mönch et al, 1996), increases in nitrogen excretion, symptoms such as vomiting, dizziness, 
nausea, fullness, diarrhoea and headaches, and in non-PKU adults, post-prandial 
hypoglycaemia. 
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Explanatory mechanism for effect of 4 hourly administration of protein 
substitute intake on plasma phenylalanine concentrations 
It is probable that continual feeding stimulates protein synthesis day and night, thereby 
increasing efficiency of protein utilisation (Millward and Rivers, 1988). It has been shown 
in a group of malnourished children achieving catch-up growth during nutritional 
rehabilitation, feeding every 4 hours, that efficiency of protein utilisation was very high 
(Ashworth and Millward, 1986; Chan and Waterlow, 1966). Similarly, in rats fed every 
4 hours, growth is more rapid and protein utilisation more efficient than in ad lib fed rats, 
which exhibit a diurnal pattern of intake (Obled, Arnal and Fauconneau, 1975). 
The only other potential operative factor, when protein substitute was given day and night, 
was that the carbohydrate added to protein substitutes increased the energy intake overnight. 
Each dose of protein substitute provided 10 to 25g carbohydrate when protein substitute was 
administered during the day only; and 9 to 13g when protein substitute was given throughout 
the day and night. Although it is unlikely the carbohydrate played a major role in variability 
in blood phenylalanine concentrations, it probably enhanced utilisation of amino acids in 
protein synthesis. 
Therefore, protein substitute is able to suppress plasma phenylalanine concentrations, 
probably by enhancing protein synthesis. Continual administration every 4 hours day and 
night is able to produce a lower and stable 24-hour plasma phenylalanine profile. This may 
possibly help to improve phenylalanine tolerance indirectly. 
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Dietary phenylalanine intake 
The studies forming the basis of this thesis have demonstrated that despite dietary anomalies 
within the PKU dietary system, which masked a significant increase in the intake of dietary 
intake of phenylalanine, there was no proof to support the suggestion that better 
phenylalanine control could be achieved by making the dietary system more rigorous. 
Therefore, there appears to be no need to incorporate some of the ‘free’ foods into the 
phenylalanine exchange system. 
It is perhaps surprising that excess or extra phenylalanine from ‘free’ fruit and vegetables did 
not affect phenylalanine concentrations. In addition to daily allocated natural protein in the 
form of 50 mg phenylalanine exchange, free foods increased natural protein intake by 49% 
and phenylalanine by 31%. A wide day to day variation in natural protein intake was seen, 
but this effect was substantially reduced when phenylalanine intake was calculated. Free 
vegetables were responsible for the majority of excess natural protein intake, and these 
included cauliflower, tinned tomatoes, fried mushrooms and onions. 
Possible mechanisms for lack of effect of extra phenylalanine from ‘free’ fruit 
and vegetables on plasma phenylalanine concentrations 
There are four possible explanations why excess phenylalanine from ‘free’ fruit and 
vegetables did not affect blood phenylalanine concentrations. 
1) Phenylalanine from fruits and vegetables may not be efficiently absorbed. It is known 
that vegetable protein is the least digestible of all proteins and a correction factor of only 
85% is given for digestibility for diets based mainly on vegetables and unrefined 
carbohydrate (Thomas, 1994). It may also be possible that the non-starch polysaccharide 
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content of some of the fruits and vegetables may reduce apparent digestibility by up to 
10% and increase nitrogen excretion in the faeces (Thomas, 1994). 
2) Diets may be lower in phenylalanine than calculated. This may be why there is no 
apparent effect of excess intake on blood phenylalanine concentrations. Due to a lack of 
contemporary and comprehensive phenylalanine data of vegetable composite dishes, it is 
impossible to accurately calculate the phenylalanine content of the PKU diet, so it is 
necessary to use some protein analysis to estimate phenylalanine intake. Children with 
PKU eat many convenience composite vegetable items, such as vegetable nuggets and 
fingers, for which there is no phenylalanine analysis, and vegetables provide less 
phenylalanine (per g of protein) than other basic foods. Phenylalanine intake may 
therefore be overestimated. 
3) The children ate more phenylalanine from free foods, which would increase their energy 
intake. This may have enhanced protein utilisation. 
4) Even with a generous ‘free’ food system in PKU, the mean daily phenylalanine intake of 
the subjects in the factors affecting the variation in plasma phenylalanine study (chapter 
2) is similar to, and indeed no greater than, two German studies documenting 
phenylalanine intake (Wendel et al, 1990; Schulz and Brumner, 1995). It is lower than 
that reported in an American study (Acosta et al, 1983) (Table 8.1), but in this study the 
blood phenylalanine concentrations were much higher than considered acceptable in the 
UK. Even in the German study on 1-6 year old children, the means of median 
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phenylalanine concentrations from 2 years of age were greater than the designated upper 
limit of 360 
Table 8.1 Intake of dietary phenylalanine 
Effect of phenylalanine intake on 24-hour plasma phenylalanine variability 
Dietary phenylalanine (from exchanges and free foods) did not cause any significant increase 
or peaks in phenylalanine concentrations. In the 24 hour blood phenylalanine variability 
study, over 30% of subjects ate more than 50% of their natural protein in the evening and 
this had no impact on blood phenylalanine control within 1 to 2 hours of meal completion. 
Comparable results have been reported by others (van Spronsen et al, 1996). They showed 
that plasma phenylalanine concentrations only increased above baseline by 10% to 18% 
when 50% of the total daily phenylalanine allowance was given and 8% to 26% 
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with 75% of the total daily phenylalanine allowance. This is in contrast to non-PKU 
individuals and may be because patients with PKU have a lower ratio of phenylalanine 
intake relative to plasma pool size (van Spronsen et al, 1993). In 12 non-PKU and 12 adults 
heterozygous for PKU, ingestion of a hamburger and milk shake meal, providing 1.0g 
protein/kg body weight significantly increased plasma amino acid concentrations over 
baseline, reaching the highest mean value 3-5 hour after a meal occurred (Stegink, 1991). 
Ashley and co-workers found that phenylalanine concentrations rose within one hour 
following a high protein meal, but decreased after a carbohydrate enriched soup (Ashley et 
al, 1982). 
Dietary energy 
Data from the factors affecting variability in plasma phenylalanine study (chapter 2), 
showed that energy intake fluctuated significantly within and between patients but did not 
appear to influence plasma phenylalanine variability. This is surprising, as energy intake, 
particularly from carbohydrate sources has been shown to be important in protein synthesis 
(Motil et al, 1981). 
The mean dietary energy intake met the EAR (DH, 1991), with carbohydrate providing the 
majority of energy and fat providing a relatively low mean intake of 23% of the energy. 
This has been reported previously in PKU, and in fact, many patients have low cholesterol 
levels (Schulpis et al, 1989; Galluzzo et al, 1985; Galli et al, 1991; Acosta et al, 1973) and a 
poor long-chain fatty acid (LC-PUFA) status (Giovannini et al, 1995). Four patients 
consumed only a mean of 80% or less than the EAR for energy (DH, 1991), but still 
achieved acceptable morning plasma phenylalanine concentrations. 
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There was no significant relationship between energy intake and overall phenylalanine 
tolerance, although there is some evidence to suggest that patients who ate higher quantities 
of excess protein from free foods had higher energy intakes. However, Güttler showed that 
the administration of a protein free snack in a child with PKU had no impact on plasma 
phenylalanine concentrations (Güttler et al, 1969). This is supported by a further case study 
in an adult with PKU, in which a high carbohydrate snack was given late in the evening and 
did not prevent the nocturnal rise in phenylalanine concentration (Farquhar et al, 1985). 
8.2.3 Rationalisation of allocation of fruit and vegetables in the 
PKU diet 
Potatoes 
These are popular phenylalanine exchanges and for years the quantity allowed per exchange 
has been underestimated. Phenylalanine analysis has been calculated indirectly from protein 
rather than by specific phenylalanine measurement. Although direct phenylalanine content 
is now available, there is no certainty of its accuracy. The phenylalanine content of potatoes 
varies according to age, variety, cooking method and measurement technique. Analyses also 
vary between different countries (Weetch et al, 1997; Bremer et al, 1996). In the potato 
study (chapter 3) which used phenylalanine exchanges based on direct phenylalanine 
measurement, portion size of potato increased by 33 to 220% according to the cooking 
method and the mean phenylalanine intake increased by 27 mg daily. It was, therefore, 
important to establish that this did not have any adverse effect on blood phenylalanine 
control. Potato phenylalanine exchanges based on direct phenylalanine measurement were 
tested daily over 5 weeks to try and detect any cumulative effect of the increase in 
226 
phenylalanine intake. A mean of two potato exchanges per day was eaten. This study 
demonstrated that it was safe to use the new potato exchanges as there was no significant 
changes in blood phenylalanine measurements in any of the patients. It is likely that the 
extra phenylalanine still provided a ratio lower to plasma phenylalanine pool size. Therefore 
the potato exchanges based on direct phenylalanine measurement have safely allowed 
significantly larger portion sizes of potato to be incorporated into the diet, a situation which 
is much appreciated by the patients. 
Fruit and vegetables containing phenylalanine between 
51-100 mg/100g 
The results of this study (chapter 4) provide opportunity to rationalise and redefine the 
allocation of fruits and vegetables containing phenylalanine between 51-100 mg/100g in the 
diet. As the diet in PKU is so limited in variety, the ability to extend the range of 
unmeasured natural foods is welcome. 
The lack of effect of additional phenylalanine from these fruit and vegetable sources was 
unexpected. Patients had a controlled increase in their median daily phenylalanine intake by 
51 mg and 39 mg on the days of dietary assessment in part 2 and 3 of the study and neither 
had any impact on phenylalanine concentrations. For patients who entered part 3 of the 
study, their natural protein intake increased from a base of 46 to 86% over allocated 
phenylalanine exchanges over the study period. There was no evidence that patients reduced 
the intake of other foods to compensate for the extra volume of food provided by these fruits 
and vegetables. 
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The reasons for the lack of impact of additional dietary phenylalanine is unclear, although 
there are a number of possible explanations: 
1) The selected test amounts of h i t s  and vegetables may not have big enough. However, 
this is unlikely as fruit and vegetables containing phenylalanine between 
51-75 mg/100g e.g. bananas, mushrooms and raisins, were popular with the patients and 
a median daily portion size of 83g for the entire five week evaluation period is a useful 
test quantity. Many young children ate one banana a day and the highest quantity 
consumed was 200g daily. Some children might exceed this quantity and eat these foods 
to excess, but this applies equally to other fruits and vegetables that may contain 
phenylalanine just less than 50 mg/100g and which are already allowed freely. The 
median portion size for vegetables containing phenylalanine between 76-100 mg/100g 
was smaller at only 50g and these were taken only three times per week. However, the 
period of phenylalanine testing was extended by a further 2 weeks and one portion of 
these vegetables had to be eaten daily during blood sampling. The largest portion sizes 
of just over 100g were eaten by patients over the age of 10 years in whom a higher 
plasma phenylalanine of up to 700 is allowed in accordance with MRC guidelines 
(MRC, 1993 b). 
2) Although these fruits and vegetables provided an increase in dietary phenylalanine, it 
may still not have been enough to alter phenylalanine concentrations as the daily 
phenylalanine is delivered in divided doses at and between mealtimes. 
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3) The non-starch polysaccharide content of the fruit and vegetables may have reduced their 
digestibility. 
4) A concomitant increase in energy with the addition of the fruit and vegetables is unlikely 
to have had a major impact on protein utilisation. Energy only increased by a modest 
68 kcal and 40 kcal daily for part two and three of the study, respectively. 
It would therefore appear safe to incorporate fruits and vegetables tested in this study 
containing phenylalanine between 51-75 mg/100g into the diet without restriction. The 
evidence would also suggest that fruit and vegetables containing phenylalanine between 
76-100 mg/100g could be incorporated without measurement. However, the portion size 
tested in the second part of this study was modest, and although there was no evidence that 
they had any impact on plasma phenylalanine concentrations, they should probably be 
restricted to one portion daily until further data is available. 
In conclusion, the overall work on the phenylalanine content of fruit and vegetables and 
effect on plasma phenylalanine concentrations has provided evidence to enable the PKU diet 
to be more rationally based, but at the same time has increased free food choice and hence 
tolerability of the diet. 
8.2.4 Effect of diet on feeding behaviour in young children with 
PKU 
The study reported in chapter 7 is the first to describe the extent of feeding problems in 
young children with PKU. Forty-seven per cent of mothers perceived their children to have 
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at least three feeding difficulties. Principal problems perceived and observed was slowness 
to feed, a poor appetite, a dislike of sweet foods and a limited variety of foods consumed. 
Parents perceived their children to have more gastrointestinal symptoms whilst it was 
observed that carers of PKU children resorted to more mealtime coercive strategies to 
persuade their children to eat, used less verbal encouragement at mealtimes and were more 
likely to feed their children in isolation. Although PKU children were lighter and smaller 
than control children, only two PKU children were stunted (height age more than 2 standard 
deviations below reference value). However, both of these children had at least one small 
parent, and neither had low energy intakes. 
Energy intake 
Although it was clear from carer’s perception and observed video work that children with 
PKU had a poor appetite, they still achieved a median energy intake equivalent to the EAR. 
In most children with PKU, the protein substitute provided over 30% of the energy intake. 
This was through the use of XP Maxamaid (Scientific Hospital Supplies), which is 
supplemented with carbohydrate. An average daily toddler dose provided 370 kcal, and it is 
likely this suppressed appetite and so reduced energy intake from other foods. It is 
interesting to note that two children who took a protein substitute providing less than 20% of 
energy intake appeared to have less feeding difficulties. Carers were not generally aware of 
the amount of energy supplied by the protein substitute. Therefore, they may have had 
unrealistic expectations of how much food their children should eat and may have 
exacerbated feeding problems by coercing children to eat when they were not hungry. 
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Parental feeding strategies 
It was clear that the carers of PKU children were more likely to cajole their children to eat, 
and to resort to bribery, and even threats. However, apparent poor food intake may not have 
been the only cause of this. Dietitians emphasise the importance of eating a set number of 
phenylalanine exchanges per day and carers may become preoccupied in ensuring all 
exchanges are eaten by their children. Repeated exchange refusal may lead carers to attempt 
to over-ride behaviour signals of satiety in their children. This in turn may help to nurture 
and sustain feeding problems and contribute to the increased incidence of negative feeding 
behaviour. Coercive mealtime management is known to make mealtimes unpleasant for 
children (Harris and Booth, 1987). 
Carers were less likely to sit with PKU children at mealtimes and give verbal encouragement 
and praise to persuade them to eat. In practice, carers had to prepare two different family 
meals, and they found it difficult to serve both simultaneously. As a result, children with 
PKU were frequently fed first and given their meals alone. However, lack of praise, 
unpleasant conversation about food and eating in isolation, can only have a negative effect 
on appetite and feeding. 
Food preferences and dislikes 
These were uncommon in the group of PKU children studied. Savoury foods were favoured 
(e.g. cucumber, tomato and crisps); food dislikes tended to be sweet (e.g. puddings, low- 
protein cakes and biscuits). It may be that the introduction of a bitter tasting protein 
substitute in early infancy influenced this preference. Furthermore, carers perceived their 
children with PKU to eat a limited range of foods even within the confines of their dietary 
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restriction. Some said they tended not to repeatedly offer food that had been initially 
refused. Food preference is, however, a function of exposure (Birch et al, 1982; Birch and 
Martin, 1982; Harris and Booth, 1987). If a child can be motivated by repeated social 
reinforcement to taste a food, then a preference for that food may be induced (Birch et al, 
1987). It has been suggested by Birch and Martin that repeated experience with and 
exposure to a food up to 15 times will eventually induce a preference (Birch and Martin, 
1982). This does, however, need careful interpretation. It should not be tried with foods to 
which there is a strong aversion, because this may induce loathing and exacerbate feeding 
problems. 
Protein substitute 
Particular problems were experienced with the administration of the protein substitutes. 
Based on L-amino acids, they are bitter tasting and produce hyperosmolar solutions when 
dissolved in water (XP Maxamaid osmolality [ 1:5 dilution] 969 mosmol/kg). They then can 
be taken as a drink or a paste. Because of extreme difficulties in giving the protein substitute, 
a third of the parents, gave the majority once daily, often in the morning and usually in a 
liquid of less than 1:5 dilution. Carers reported constipation and/or abdominal pain in four 
out of five of these children. The same children were observed to have particularly poor 
appetites and were very slow feeders. 
For all the PKU children, negative behaviour such as crying, screaming, deliberately spilling 
the drink and gagging were common when taking the protein substitute. Parents commented 
that they found administration of the protein substitute more tearful and stressful than giving 
natural food and one mother even stated that the time and effort in having to give the protein 
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substitute was ruining her family’s life. Although the taste of the protein substitute is 
probably the main cause of these problems, there is scope to examine alternative ways of 
administering protein substitute in order to alleviate these difficulties. 
This study, therefore, identified a number of feeding problems in young PKU children, some 
of which are likely to be precipitated by the protein substitute. Although the energy content 
of protein substitutes might have a beneficial role in helping to maintain an adequate energy 
intake in a restricted PKU diet, the protein substitute is probably suppressing appetite, 
particularly when administered before mealtimes. 
Although the aetiology of feeding problems may be unclear, problem solving is important in 
PKU; otherwise these difficulties may lead to years of parental frustration and stress and 
may possibly impair nutritional status. Although an optimum dietary approach in young 
children with PKU is necessarily relatively rigid, an appreciation and awareness of the 
potential consequences of such diet therapy on feeding behaviour and growth should prove 
helpful in management and may lead to better plasma phenylalanine control in young 
children with PKU. 
8.3 Potential drawbacks of individual studies 
Chapter 2: Factors affecting the variation in plasma phenylalanine in patients with 
phenylketonuria. 
Analysis of dietary phenylalanine intake 
Due to lack of comprehensive phenylalanine analysis data, the phenylalanine intake in the 
first study may have been over-estimated. There were only three UK sources of 
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phenylalanine data: 1) the First Supplement to ‘McCance and Widdowson ’s The 
Composition of Foods’ (Paul et al, 1980); 2)  the Leatherhead Food Research Association 
and the Laboratory of the Government Chemist (Weetch e? al, 1997); and 3) food 
manufacturers of special products. In total, these only provided phenylalanine analysis data 
for fruits, vegetables, some dairy products, low protein special foods, sauces and a limited 
number of cereals. For many composite foods e.g. vegetable nuggets, waffles, hash browns, 
potato shapes, phenylalanine analysis is unavailable, so it was estimated that 1 g protein 
yielded 50 mg phenylalanine (Barnes, 1994). As many fruit and vegetable only yield 30-40 
mg of phenylalanine per 1 g of protein it is likely that phenylalanine based on these 
calculations was overestimated, particularly in younger children who eat many of these 
foods as part of their phenylalanine allowance. 
Chapter 3: A prospective cross-over trial assessing the impact of new potato exchange 
allowance on blood phenylalanine concentrations in PKU. 
Chapter 4: A prospective, cross-over trial investigating the effect of free use of fruits 
and vegetables containing intermediate amounts (51 - 100 mg/100g) of phenylalanine 
on control in PKU. 
Open study design 
These were both open studies. The researcher’s enthusiasm for a specific treatment may have 
influenced the collection and interpretation of data. However, 1) the results were different 
from those anticipated by the researcher; 2) laboratory staff were blind to the treatment when 
analysing blood specimens; 3) weighed food records were used so the researcher did not 
have to interpret portion sizes; and 4) with the exception of routine blood results, all results 
were not given to parents or subjects until the end of the study. 
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Non-randomised trials 
Neither of these two studies were randomised. The test period always followed the control 
period. There were three main reasons for this: 
- the diet is very restrictive and it seemed insensitive either to reduce portion size or 
remove specific fruit and vegetables when they had previously been permitted freely. 
- the trial period was always longer than the control period to ensure there was sufficient 
time for the extra phenylalanine taken to influence plasma phenylalanine concentrations. 
- to help with compliance, as the second stage trial phase always permitted extra food. It 
may be expected that the plasma phenylalanine concentrations in the second stage of the 
trial may be higher due to study fatigue, but there is no evidence to indicate this. 
Recruitment 
This was difficult due to inability to eat the specified quantity of potatoes, fruit, and 
vegetable being studied. 
Chapter 5: 24-hour plasma phenylalanine variability in PKU. 
Blood sampling: venous sampling technique versus skin puncture 
A combination of venous blood sampling and thumb skin punctures were incorporated into 
the protocol: hourly venous sampling during the day in hospital and 3 hourly thumb, heel or 
finger skin punctures overnight. Although it is widely presumed there is little difference in 
the results between thumb skin puncture and venous sampling techniques, there are no 
published data to support this. It is likely that the quality of skin puncture analysis is 
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influenced by operator skill, and in these studies all parents were trained and experienced at 
taking skin puncture blood specimens. 
Subjects were studied for only 24 hours 
It was considered unethical to ask subjects to repeat the 24-hour testing. It would also have 
been practically difficult, as subjects would have needed hospital admission for any study 
extension. 
Chapter 6a: the effects of altered timing of administrations of protein substitute on 
variability in plasma phenylalanine concentrations. 
Chapter 6b: the effects of frequent administration of protein substitute on plasma 
phenylalanine concentrations. 
No washout time between protocols 
This was for three reasons: 
- Previous study work (chapter 2 and 5) suggested that adjusting timing of protein 
substitute had an immediate effect on plasma phenylalanine concentrations, probably 
because metabolism of the protein substitute is rapid. 
- There was a 5 day period to adapt to taking the protein substitute before blood sampling. 
This was considered adequate to have counteracted any effects of a previous regimen. 
- Washout time would have increased overall time taken to complete the study, which may 
have influenced recruitment and compliance. 
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Chapter 7: Abnormal feeding behaviours in PKU 
Control group 
Each child with PKU had only one matched control, so for outcome measures with wide 
individual variations it is difficult to draw definite conclusions. However, because it was 
only practical to study one matched control, these were matched for age, sex, housing and 
location, and each subject was studied in detail. 
Video recording 
There was a design problem of the video recording in that it was carried out in the home, and 
it was impossible to hide the camera. This may have acted as an added distraction for the 
child during the mealtime or caused carers to modify their feeding strategies. However, all 
the children became acquainted with the researcher before the mealtime, and had an 
opportunity to examine and play with the camera. In addition, this methodology was applied 
equally to both groups. 
Dietary assessment 
Three-day estimated food records, rather than weighed food intakes, were used to describe 
food intake. This was for two reasons: 1) only information about food types, patterns and a 
broad estimate of macronutrient intake was required; and 2) to encourage compliance of the 
control group. However, many children’s snacks were individually portioned, and weights 
quoted on the packaging helped with interpretation of portion sizes. The parents of PKU 
children continued to weigh all phenylalanine exchanges and protein substitute. All food 
records were checked with parents for any food omissions. 
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NB. In all studies a higher proportion of females to males were enrolled. This is a reflection 
of the under 10 year old population of children attending the Birmingham Children’s 
Hospital, which is predominantly female. However no gender difference has been noted in 
non-PKU children with blood phenylalanine concentrations, although adolescent males have 
been shown to have slightly higher phenylalanine concentrations than females (Gregory et 
al, 1986). 
8.4 Unanswered questions and future research 
24 hour variability of plasma phenylalanine concentrations 
The effect of wide 24-hour variability of plasma phenylalanine concentrations in PKU can 
only remain speculative. There is only tenuous evidence to link transient 
hypophenylalaninaemia with poor growth or neurological outcome. This can only be 
answered by long term, controlled prospective trials where the diet is manipulated to ensure 
transient hypophenylalaninaemia for 50% of the day. 
Optimum timing for administration of protein substitute 
The results of this study suggest that the optimum protein substitute administration regimen 
to achieve a stable blood phenylalanine profile over 24 hours, is to give small doses at least 
every 4 hours day and night. This is impractical. Some children under 8 years of age have 
great difficulty in keeping awake after 21.00 hours. Alternative approaches need to be 
explored and investigated. Enteral feeding of protein substitute represents an alternative 
method. However, this is expensive, invasive and difficult for both patients and parents. 
Perhaps manufacturers should explore the concept of developing protein substitutes to 
release amino acids at different and slower rates. This may be afforded by the use of 
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thermally modified starches, which are currently being investigated as potential sustained 
release agents for oral-drug delivery (Remon et al, 1996). Realisation of this approach could 
lead to a regimen of fewer protein substitute doses over 24 hours. This would not only be 
more acceptable and convenient to patients, but also would reduce plasma phenylalanine 
variability and may increase phenylalanine tolerance. Further study is warranted. 
Optimum daily dosage of protein substitute 
The 24-hour plasma phenylalanine variability results reported in this thesis are different 
from those reported by van Spronsen (van Spronsen et al, 1993). This may relate to the 
higher daily dose of protein substitute used in the UK. As protein substitute suppresses 
plasma phenylalanine concentrations, higher total daily dosage may increase difference in 
phenylalanine variability seen i.e. the more protein substitute given, the bigger the 
fluctuations in phenylalanine concentrations. The most appropriate dose of protein 
substitute in PKU as not been determined. Although it is likely to be age and weight 
dependent, it should perhaps vary according to the severity of PKU. Carefully controlled 
trials are urgently needed to determine the optimum daily dose of protein substitute in PKU. 
Practical administration and composition of protein substitute 
In the feeding problem study, it is likely that the energy content, timing and administration 
of protein substitute in the form of a large drink inhibited appetite, contributed to the 
gastrointestinal symptoms and caused some of the feeding difficulties observed. 
Since completing this study, it is now our normal practice to give the protein substitute as a 
paste, usually in 3-4 doses daily. Only a small volume of the product is taken at one time 
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and there appears to be a lower incidence of gastrointestinal symptoms. Difficulties with 
protein substitute administration also appear to have decreased but appropriate investigation 
is needed before any conclusions can be drawn. The effect of energy content of protein 
substitute, and it’s method and timing of administration on appetite requires further 
controlled study. 
8.5 Conclusion 
Although the structure of the PKU diet used in the UK is relatively relaxed and flexible, this 
work highlights the many practical problems and adverse effects on feeding behaviour that 
such a rigid diet can cause. The need to maintain low blood phenylalanine concentrations in 
PKU is unequivocal. However, this work has demonstrated the wide variability in blood 
phenylalanine concentrations over 24 hours and the difficulties in interpreting single blood 
phenylalanine estimations. Plasma phenylalanine variability can be reduced to almost 
normal physiological changes by regular and more frequent administration of protein 
substitute day and night. It has also been demonstrated that it is better to use food 
phenylalanine content to estimate intake rather than protein content as the latter over- 
estimates phenylalanine intake. This work has enabled the phenylalanine exchange and free 
system to be rationalised in PKU. This in turn has led to further relaxation of the diet, and 
will hopefully help make the diet easier. Overall, this work has provided further insight into 
the effects of the different dietary components on blood phenylalanine concentrations; and 
has demonstrated the many problems faced by parents and children with PKU. 
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Sample daily food intake 
Breakfast 
Mid-morning 
Midday 
Mid-afternoon 
Evening meal 
Bedtime 
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Video Analysis Category System 
(Adapted from Thomas and Harris 1993) 
1. Meal duration. 
2. Number of mouthfuls during meal. 
Child feeding behaviour during the mealtime 
1. Number of times child turns head away when offered food by parent. 
2. Number of times child closes mouth when offered food. 
3. Number of times child is redirected from the task of eating 
4. Number of times child redirects self to the task of eating. 
5. Number of positive vocalizations from child. 
6. Number of negative vocalizations from child. 
7. Does child spit food during meal? Yes/ No. 
8. Does child feed self without prompting from parent at start of meal? Yes/No. 
Parental intervention during the meal 
1. Number of times parent offers food to child. 
2. Number of vocalizations made by the parent: 
- feeding directed vocalization 
- prompting or redirecting child to task 
- bribing 
- praising 
- threatening 
- distracting 
3 Is there any use of distracter items by the parent during the meal? Yes/No 
4 Parental mealtime strategy if child does not finish course/meal: 
- take it away? Yes/No 
- attempt to make child eat food? Yes/No 
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- 
- offer next course? Yes/No 
- 
distract the child to eat? Yes/No 
offer child reward for eating? Yes/No 
Definitions of categories used in video analysis 
1 Meal duration. Time taken from when the plate is placed before the child to when 
the plate is taken away from the child 
One mouthful. When child or parent places food in child’s mouth. This does not 
include nibbling food and the food should be enough for child to chew. 
2 
Definition of child behaviour 
1. Child turns head away when proffered food by parent. Child is seen to turn head 
away from the food being directly offered by the parent usually on a spoon or fork. 
2. Child closes mouth when proffered food by parent. Child is seen to close mouth 
when the parent directly offers the food usually on a spoon. 
3. Child is redirected away from the task of eating; child is seen to turn away from 
the task of eating or drinking and to concentrate on some other activity. This 
includes turning their head or body away from the plate, getting out of their chair or 
being distracted by other objects (e.g. by toys or the television) for a period of ten 
seconds after the last mouthful is finished. This movement should be self-induced and 
not as a result of vocalization from the mother. 
4. Child redirects from the task of eating. This is when the child is seen to open their 
mouth and let the food or drink drop from their mouth or remove the food from their 
mouth forcibly with their tongue. 
5 .  Feeding/drinking without prompting from parent. This is when the child is seen to 
start eating/drinking without being told by a parent. 
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Definition Of parental non-verbal intervention 
1. Parent proffers food to child. A direct attempt to offer food to the child, usually by 
placing food on a spoon or fork and lifting it up to the child’s mouth or by putting a 
cup next to the mouth. 
2. Does the parent use a distracter item during the meal? This could be anything 
from giving a toy, turning the television on during the meal. 
3. Parental mealtime strategy if child does not finish meal. Defined when child 
indicates that they have had enough to eat by some form of verbalization or action 
having not completed the meal. 
Definitions of parent/child vocalizations 
The end of one vocalization is defined by a natural pause in the speech of the parent or 
child. 
1 .  Positive vocalizations from the child. Positive speech from the child about the food 
without prompting from the parent e.g. a request for some more food or verbalization 
from the child illustrating their like for something they are eating. 
2. Negative vocalization from the child. Negative speech from the child about food 
without prompting from the parent e.g. verbalization from the child saying they 
dislike something they are eating, or saying they don’t want to eat any more. 
3. Feeding directed verbalization from parent. Speech from the parent associated 
with the food being eaten e.g. asking the child “is that nice?” or “is the food too hot?” 
4. Prompting or redirecting the child to the task. Direct speech from the parent 
reminding or encouraging the child to eat, usually because they are showing an 
interest in something other than the food in front of them e.g. “eat some more please” 
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5. Bribing. Speech from the parent promising some reward in order to encourage the 
child to eat e.g. “if you eat the rest you can have.. .” 
6. Praising. Positive speech from the parent towards the child to show them that they 
are pleased that they are eating e.g. “good girl” or “good boy.” 
7. Threatening. Speech from the parent implying a negative consequence if the child 
does not eat what the parent wishes them to e.g. “if you don’t eat it.. . .” 
8. Distracting. Speech from the parent with no direct reference to the eating situation 
accompanied by the parent offering food to the child. 
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